







 
 
  







<HTML>
<HEAD>
<TITLE>JBC --  Wick et al. 275 (51): 40400</TITLE>


	<SCRIPT LANGUAGE="JavaScript">
	<!--
	function startTarget(windowname,wid,hei) {
	
	var dotpos = windowname.indexOf(".");
	if (dotpos > -1)
	{
	var tempwn = windowname.substring(0,dotpos) +
		windowname.substring(dotpos + 1, windowname.length);
	windowname = tempwn;
	}
	var sizestring = 'width=' + wid + ',height=' + hei;
	window.open('',windowname,'scrollbars,resizable,' + sizestring + '\'');
	}
	// -->
	</SCRIPT>



	<!-- has inhead tag -->
	 
	 
	<script language="JavaScript">
	<!--
	if ( top != self )
	{
		top.location.href = unescape(window.location.pathname);
	}
	//-->
	</script>
	
	

<meta name="robots" content="nofollow">
</HEAD>
<BODY BGCOLOR="#FFFFFF" 
	
		
			
		
	>



<A NAME="top"><!-- null --></A>

	
	<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0">
	<TR>
		<TD VALIGN="BOTTOM" NOWRAP>
			<A TARGET="_top" STYLE="text-decoration: none" HREF="/"><IMG BORDER="0" WIDTH="220" HEIGHT="44" ALT="JBC" SRC="/icons/banner/title.gif"></A>
			<A TARGET="_top" HREF="/cgi/adclick?journal=jbc&ad=Roar%20Biomedical&url=http://www.roarbiomedical.com&side=only"><IMG BORDER=2 WIDTH=220 HEIGHT=40 SRC="/ads/gifs/1049907330.gif" ALT="CETP activity inhibitor screens"></A><BR><IMG ALT="" WIDTH="1" HEIGHT="3" SRC="/icons/spacer.gif"><BR>
			
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue51/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	</TD>
		<TD><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
		<TD VALIGN="BOTTOM">
	
	<TABLE CELLPADDING="0" CELLSPACING="1" BORDER="0" BGCOLOR="#000000"><TR>
	<FORM METHOD="GET" NAME="search" ACTION="/cgi/search"><INPUT TYPE="hidden" NAME="andorexactfulltext" VALUE="and"><INPUT TYPE="hidden" NAME="resourcetype" VALUE="1"><INPUT TYPE="hidden" NAME="disp_type" VALUE="">
	<TD ALIGN="CENTER" VALIGN="MIDDLE"> 
		<TABLE CELLPADDING="1" CELLSPACING="0" BORDER="0" BGCOLOR="#DBDBDB"> 
		<TR>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD VALIGN="MIDDLE"  BGCOLOR="#006699" NOWRAP><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#FFFFFF"><EM>QUICK</EM> SEARCH:&nbsp;</FONT></STRONG></TD>
			<TD ALIGN="RIGHT" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A STYLE="text-decoration:none;color:#FFFFFF" HREF="/search.dtl"><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">&nbsp;[advanced]</FONT></A></TD>
			<TD BGCOLOR="#006699"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR><TR>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
			<TD BGCOLOR="#DBDBDB" COLSPAN="2">
			<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0"> 
			<TR>
				<TD ALIGN="CENTER" VALIGN="BOTTOM"><INPUT TYPE="submit" STYLE="text-decoration:none;font-family:verdana,arial,helvetica;font-size:10px;font-weight:bold;color:#000000;background:#FFFFFF;" VALUE="Go"></TD>
				<TH ALIGN="LEFT" COLSPAN="2"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Author:<BR></FONT>
					<INPUT TYPE="text" NAME="author1" SIZE="9" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
				<TH ALIGN="LEFT" COLSPAN="3"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Keyword(s):<BR></FONT>
					<INPUT TYPE="text" NAME="fulltext" SIZE="16" MAXLENGTH="80" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TH>
			</TR><TR>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Year:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="pubdate_year" SIZE="4" MAXLENGTH="4" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH ALIGN="RIGHT"><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Vol:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="volume" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
				<TH><FONT SIZE="-2" FACE="verdana,arial,helvetica,sans-serif" COLOR="#000000">Page:&nbsp;</FONT></TH>
				<TD><INPUT TYPE="text" NAME="firstpage" SIZE="4" MAXLENGTH="10" VALUE="" STYLE="font-family:verdana,arial,helvetica;font-size:10px;"></TD>
			</TR> 
			</TABLE> </TD>
			<TD BGCOLOR="#DBDBDB"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"></TD>
		</TR>
		</TABLE></TD></FORM></TR></TABLE> 
	 
	</TD>
	</TR><TR>
		<TD COLSPAN="3"><IMG ALT="" WIDTH="2" HEIGHT="2" SRC="/icons/spacer.gif"><BR>







	
	

	




	


	
	
	
	 

	


	
	




				<BR><FONT SIZE="-2" FACE="verdana,arial,helvetica">
	<NOBR><STRONG>Institution: Cornell University Medical College</STRONG></NOBR>
	<NOBR><A TARGET="_top" HREF="/cgi/login?uri=%2Fcgi%2Fcontent%2Ffull%2F275%2F51%2F40400">Sign In as Member/Non-Member</A></NOBR>
	
		
		
	
	</FONT>
	
 <!-- showauthstring -->
	<!-- INST -->
	<!-- INDV -->
        <!-- SPONSORED -->
	<!-- USER.PFA -->
	<!-- USER.PFABSAIC -->
	<!-- NOT GUEST -->
	

	
<HR ALIGN="LEFT" SIZE="1" COLOR="#000000" NOSHADE></TD>
	</TR>
	</TABLE>
	



         
                
        



	
		
		
	 
 




		<FONT COLOR="#A70716"></FONT>
	
	<FONT SIZE=-1>Originally published In Press as  <A HREF="/cgi/content/abstract/M003937200v1">doi:10.1074/jbc.M003937200</A> on September 26, 2000</FONT>


	
		
		<P><FONT SIZE=-1>J. Biol. Chem., Vol. 275, Issue 51, 40400-40406, December 22, 2000</FONT><BR>
		
	

 

 
	  
		                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/51/40400">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/51/40400">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/51/40400">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/51/40400&title=Mechanism+of+Phosphorylation+of+Protein+Kinase+B%2FAkt+by+a+Constitutively+Active+3-Phosphoinositide-dependent+Protein+Kinase-1">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M003937200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=11006271&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=11006271&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		
		<TR><TD><FONT SIZE="-1">
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="#otherarticles">other online articles</A>
		</FONT></TD></TR>
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Wick+MJ&link_type=AUTHORSEARCH">Wick, M. J.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Liu+F&link_type=AUTHORSEARCH">Liu, F.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/51/40400&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F51%2F40400"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/51/40400">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/51/40400<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M003937200v1">M003937200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


	









 





	
	
	
	
	
	
	
	
	
		<vardef id="TEXT">

<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->





<H2>
<FONT COLOR=A70716 SIZE=-1>

</FONT>

    Mechanism of Phosphorylation of Protein Kinase B/Akt  by a
Constitutively Active 3-Phosphoinositide-dependent 
Protein Kinase-1<A HREF="#FN150"><SUP>*</SUP></A>
    <BR>


</H2>



<STRONG>
<NOWRAP>
Michael J. 
Wick<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>,<WBR>
Lily Q. 
Dong<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>,<WBR>
Ramon A. 
Riojas<SUP>&#167;</SUP>,<WBR>
Fresnida J. 
Ramos<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>, and<WBR>
Feng 
Liu<SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP><SUP>&#167;</SUP><A HREF="#FN154"><SUP>&#182;</SUP></A>
</NOWRAP>
</STRONG>
<P>
From the Departments of <SUP><IMG SRC="/math/12pt/normal/Dagger.gif" ALIGN=BASELINE ALT="Dagger "></SUP>&nbsp;Pharmacology and
<SUP>&#167;</SUP>&nbsp;Biochemistry, The University of Texas Health Science
Center, San Antonio, Texas 78229
<P>
Received for publication, May 9,&nbsp;2000, and in revised form, September 5,&nbsp;2000
<P>






    
	
	    
	
	    
		
    
	
	    
	
    
	
	    
	
    
    
	
	    
	
    







<a name = "Abstract"><!-- comment for mosaic --></a>



<BR CLEAR=ALL><A NAME="Abstract"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABSTRACT</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>ABSTRACT</FONT>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

<P>Phosphorylation of Thr<SUP>308</SUP> in the
activation loop and Ser<SUP>473</SUP> at the carboxyl terminus is
essential for protein kinase B (PKB/Akt</A>)<SUP> </SUP>activation. However, the
biochemical mechanism of the phosphorylation<SUP> </SUP>remains to be
characterized. Here we show that expression of a<SUP> </SUP>constitutively active
mutant of mouse 3-phosphoinositide-dependent<SUP> </SUP>protein
kinase-1 (PDK1<SUP>A280V</SUP>) in Chinese hamster ovary cells
overexpressing the insulin receptor<SUP> </SUP>was sufficient to induce PKB
phosphorylation at Thr<SUP>308</SUP> to approximately the same extent
as insulin stimulation. Phosphorylation<SUP> </SUP>of PKB by PDK1<SUP>A280V</SUP>
was not affected by treatment of cells with inhibitors of
phosphatidylinositol<SUP> </SUP>3-kinase or by deletion of the pleckstrin homology
(PH) domain<SUP> </SUP>of PKB. C<SUB>2</SUB>-ceramide, a cell-permeable, indirect
inhibitor of PKB<SUP> </SUP>phosphorylation, did not inhibit
PDK1<SUP>A280V</SUP>-catalyzed PKB phosphorylation in cells and had no
effect on PDK1</A><SUP> </SUP>activity <I>in vitro</I>. On the other hand,
co-expression of full-length<SUP> </SUP>protein kinase C-related kinase-1
(PRK1/PKN) or 2&nbsp;(PRK2) inhibited<SUP> </SUP>PDK1<SUP>A280V</SUP>-mediated PKB
phosphorylation. Replacing alanine at position 280<SUP>&nbsp;</SUP>with valine or
deletion of the PH domain enhanced PDK1</A> autophosphorylation<SUP> </SUP><I>in
vitro</I>. However, deletion of the PH domain of
PDK1<SUP>A280V</SUP> significantly reduced
PDK1<SUP>A280V</SUP>-mediated phosphorylation of PKB in cells. In
resting cells, PDK1<SUP>A280V</SUP> localized in the cytosol and at
the plasma membrane. However,<SUP> </SUP>PDK1<SUP>A280V</SUP> lacking the PH
domain localized predominantly in the cytosol.<SUP> </SUP>Taken together, our
findings suggest that the wild-type PDK1</A> may<SUP> </SUP>not be constitutively
active in cells. In addition, activation<SUP> </SUP>of PDK1</A> is sufficient to
phosphorylate PKB at Thr<SUP>308</SUP> in the cytosol. Furthermore,
the PH domain of PDK1</A> may play both<SUP> </SUP>positive and negative roles in
regulating the <I>in vivo</I> function<SUP> </SUP>of the enzyme. Finally,
unlike the carboxyl-terminal fragment<SUP> </SUP>of PRK2, which has been shown to
bind PDK1</A> and allow the enzyme<SUP> </SUP>to phosphorylate PKB at both
Thr<SUP>308</SUP> and Ser<SUP>473</SUP>, full-length PRK2 and its
related kinase PRK1/PKN may both play<SUP> </SUP>negative roles in PKB-mediated
downstream biological<SUP> </SUP>events.
<BR><BR CLEAR=ALL>




<TXT>
<A NAME="SEC0"><!-- comment for mosaic --></A>

    
    

    
    

    
    
	
	
	
<BR CLEAR=ALL><A NAME="Introduction"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;INTRODUCTION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>INTRODUCTION</FONT>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>

    

<P>Protein kinase B (PKB or
Akt)<SUP>1</SUP> is a Ser/Thr protein
kinase that has been shown to play an important role in the regulation<SUP> </SUP>of a wide spectrum of cellular signaling events, including
insulin-stimulated<SUP> </SUP>glucose transporter GLUT4 membrane translocation,
anti-apoptosis,<SUP> </SUP>protein synthesis, and glycogen metabolism (<A HREF="#B1">1</A>).
</P>
<P>Phosphorylation of Thr<SUP>308</SUP> in the activation loop and
Ser<SUP>473</SUP> at the carboxyl terminus is essential for PKB
activation (<A HREF="#B2">2</A>, <A HREF="#B3">3</A>).<SUP> </SUP>Although it has been shown that phosphorylation of
PKB at Thr<SUP>308</SUP> is catalyzed by
3-phosphoinositide-dependent protein kinase-1<SUP> </SUP>(PDK1</A>) (<A HREF="#B4">4</A>, <A HREF="#B5">5</A>),
the effector of PKB Ser<SUP>473</SUP> phosphorylation remains
controversial. Because PDK1</A> does not<SUP> </SUP>phosphorylate PKB at
Ser<SUP>473</SUP>, it has been suggested that phosphorylation at this
site is catalyzed<SUP> </SUP>by a distinct but yet to be characterized enzyme
termed PDK2 (<A HREF="#B6">6</A>).<SUP> </SUP>On the other hand, it has been shown that PDK1</A>,
through an interaction<SUP> </SUP>with a PDK1-interacting fragment (PIF</A>) derived
from the carboxyl<SUP> </SUP>terminus of PRK2, can switch its substrate
specificity to phosphorylate<SUP> </SUP>PKB at Ser<SUP>473</SUP> <I>in
vitro</I> (<A HREF="#B7">7</A>). Alternatively, it has recently been reported<SUP> </SUP>that
phosphorylation of the wild-type but not the kinase-inactive<SUP> </SUP>PKB at
Thr<SUP>308</SUP> triggers phosphorylation at Ser<SUP>473</SUP>,
suggesting that phosphorylation of PKB at Ser<SUP>473</SUP> occurs
through an autophosphorylation mechanism (<A HREF="#B8">8</A>).
</P>
<P>The current model of PKB activation suggests that the enzyme
undergoes mitogen-stimulated translocation to the plasma membrane,<SUP> </SUP>which is mediated by the binding of phosphatidylinositol 3-kinase<SUP> </SUP>(PI3K</A>) products, namely PtdIns</A>(3,4)P<SUB>2</SUB> and
PtdIns</A>(3,4,5)P<SUB>3</SUB>, to<SUP> </SUP>the PH domain of PKB. This binding also
leads to a conformational<SUP> </SUP>change that exposes Thr<SUP>308</SUP> and
Ser<SUP>473</SUP> to the membrane-associated and constitutively
activated upstream<SUP> </SUP>kinases PDK1</A> and PDK2, respectively. This model is
supported by<SUP> </SUP>the finding that myristoylation/palmitoylation of
PKB is sufficient<SUP> </SUP>to induce phosphorylation of the enzyme at
Thr<SUP>308</SUP> and Ser<SUP>473</SUP> (<A HREF="#B9">9</A>). In addition, PDK1</A>
purified from cells is constitutively<SUP> </SUP>active, and treatment of cells
with mitogen does not stimulate<SUP> </SUP>PDK1</A> activity <I>in vitro</I> (<A HREF="#B4">4</A>).
However, there are some data suggesting<SUP> </SUP>that the PH domain of PKB is
not necessary for PKB phosphorylation<SUP> </SUP>and activation. First, it has
been shown that PKB constructs lacking<SUP> </SUP>the PH domain can still be
activated by insulin and insulin-like<SUP> </SUP>growth factor-1 (<A HREF="#B10">10</A>, <A HREF="#B11">11</A>). In
addition, the activity of a membrane-targeted<SUP> </SUP>PKB by
myristoylation/palmitoylation is still sensitive to the<SUP> </SUP>PI3K</A> inhibitor
LY294002 (<A HREF="#B9">9</A>). These data suggest that activation<SUP> </SUP>of a PKB upstream
kinase plays an important role in the phosphorylation<SUP> </SUP>and activation
of<SUP> </SUP>PKB.
</P>
<P>In the current study, we examined the phosphorylation mechanism of PKB
using a constitutively active mutant of mouse PDK1</A>,<SUP> </SUP>PDK1<SUP>A280V</SUP>, in which the alanine at position 280&nbsp;was
replaced with valine.<SUP> </SUP>We have found that ectopic expression of
PDK1<SUP>A280V</SUP> resulted in a marked increase in PKB
phosphorylation at Thr<SUP>308</SUP> to an extent similar to that
induced by insulin stimulation.<SUP> </SUP>The PDK1<SUP>A280V</SUP>-mediated
phosphorylation of PKB was not affected by treatment<SUP> </SUP>of cells with the
PI3K</A> inhibitors wortmannin and LY294002, nor<SUP> </SUP>by ceramide, a compound
known to indirectly inhibit PKB phosphorylation<SUP> </SUP>(<A HREF="#B12">12</A>). Deletion of the
PH domain of PKB had little effect on<SUP> </SUP>PDK1<SUP>A280V</SUP>-mediated
phosphorylation of PKB. On the other hand, deletion<SUP> </SUP>of the PH domain of
PDK1<SUP>A280V</SUP> inhibited the phosphorylation of PKB in cells.
Taken together,<SUP> </SUP>our data suggest that wild-type PDK1</A> may not be
constitutively<SUP> </SUP>active in cells. In addition, the PH domain of PDK1</A> may
play both<SUP> </SUP>a positive and a negative role in regulating the function of
the<SUP> </SUP>enzyme in cells. Finally, we have found that overexpression of<SUP> </SUP>the
full-length PRK1/PKN or PRK2 inhibited PDK1<SUP>A280V</SUP>-mediated
PKB phosphorylation, suggesting that these enzymes play<SUP> </SUP>negative roles
in PKB-mediated downstream<SUP> </SUP>signaling.
<BR><BR CLEAR=ALL>



<A NAME="SEC1"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;EXPERIMENTAL PROCEDURES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>EXPERIMENTAL PROCEDURES</FONT>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Cell Lines, cDNAs, and Antibodies--</I>

A Chinese hamster
ovary (CHO</A>) cell line overexpressing the human insulin receptor
(CHO/IR) and the cDNA encoding human PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "><SUP> </SUP>were gifts from Dr.
Richard A.&nbsp;Roth. cDNA encoding mouse PDK1</A><SUP> </SUP>and a polyclonal antibody
against the protein were described previously<SUP> </SUP>(<A HREF="#B13">13</A>). The cDNA
encoding the FLAG-tagged PRK1/PKN, PRK2, and<SUP> </SUP>the carboxyl-terminal
fragment of PRK1/PKN (AF3-PKN) were gifts<SUP> </SUP>of Drs. Hideyuki Mukai and
Yoshitaka Ono and have been described<SUP> </SUP>previously (<A HREF="#B14">14</A>). Anti-PKB and
anti-phospho-PKB antibodies (Thr<SUP>308</SUP> and Ser<SUP>473</SUP>)
were obtained from New England BioLabs. Monoclonal antibody<SUP> </SUP>to the
FLAG-tag was purchased from IBI-Kodak. Polyclonal and monoclonal<SUP> </SUP>anti-Myc antibodies were from BABCO and Santa Cruz Biotechnologies,<SUP> </SUP>Inc., respectively. The anti-GST-polyclonal antibody was generated<SUP> </SUP>by
immunizing a rabbit with GST</A> and was affinity-purified.



    

    


<P><I>Site-directed Mutagenesis--</I>

Myc-tagged PDK1<SUP>A280V</SUP>,
PKB<SUP>T308A</SUP>, and PKB<SUP>K179A</SUP> were generated by
single-stranded site-directed mutagenesis according to the protocol as
described<SUP> </SUP>by Kunkel (<A HREF="#B15">15</A>) using customized primers. All site-directed
mutagenesis<SUP> </SUP>products were confirmed by restriction mapping and DNA
sequencing.<SUP> </SUP>The kinase inactive mutant PDK1<SUP>K114G</SUP> was
described previously (<A HREF="#B13">13</A>).



    

    


<P><I>Generation of Myc-tagged and PH Domain-deleted Mutants of PDK1</A>
and PDK1<SUP>A280V</SUP>--</I>

cDNAs encoding mouse PDK1</A> or
PDK1<SUP>A280V</SUP> with a truncation in the PH domain (PDK1</A>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH)
and PDK1<SUP>A280V</SUP>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH); residues 1-459) were generated by
PCR</A>, using either PDK1</A><SUP> </SUP>or PDK1<SUP>A280V</SUP> cDNA as a
template. The PCR</A> primers used were:
5'-GC<U>GAATTC</U>GACTTGGGGCTCATGGCC-3'<SUP> </SUP>and
5'-GC<U>TCTAGA</U>CTGGTGCCAAGGGTTTCC-3', with the added
restriction<SUP> </SUP>sites <I>underlined</I>. After restriction digestion
with <I>Eco</I>RI and <I>Xba</I>I,<SUP> </SUP>the cDNA fragments were
subcloned into the mammalian expression<SUP> </SUP>vector pcDNA3.1-Myc-His-A
(Invitrogen, San Diego, CA), in-frame<SUP> </SUP>with a sequence encoding a
Myc-tag at the 3'-end.



    

    


<P><I>Generation of FLAG-tagged PH Domain-truncated Mutant of
PKB--</I>

cDNAs encoding the PH domain-truncated mutant of PKB were
amplified by PCR</A> using human PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> cDNA as a template. The forward<SUP> </SUP>PCR</A> primers for full-length and the PH domain-deleted PKB were:<SUP> </SUP>5'-CCG<U>GAATTC</U>TATTGTGAAGGAGGGTTGG-3' and
5'-CCG<U>GAATTC</U>CATCCAGACTGTGGCTGAC-3',<SUP> </SUP>respectively. The
reverse primer for both constructs was
5'-CTAG<U>TCTAGA</U>GTAGGAGAACTGGGGGAAG-3',<SUP> </SUP>with the added
restriction sites <I>underlined</I>. The cDNA fragments<SUP> </SUP>were
subcloned into the <I>Eco</I>RI/<I>Xba</I>I sites of pFLAG-CMV2
vector<SUP> </SUP>(Sigma), in-frame with the sequence encoding a FLAG-tag at the<SUP> </SUP>5'-end.



    

    


<P><I>Cell Culture, Immunoprecipitation, and Western Blot--</I>

CHO/IR
cells were grown in Ham's F-12 medium (Life Technologies) supplemented
with 10% newborn calf serum and 1% penicillin/streptomycin.<SUP> </SUP>Co-transfections of CHO/IR cells were normally performed in 60-mm<SUP> </SUP>plates with 2&nbsp;&#181;g of each recombinant plasmid, using LipofectAMINE<SUP> </SUP>reagent according to the manufacturer's protocol (Life Technologies).<SUP> </SUP>Twenty-four hours after transfection, cells were serum-starved<SUP> </SUP>for 2-4
h, treated with or without 10&nbsp;n<font size=-1>M</font> insulin, and lysed in<SUP> </SUP>120-400 &#181;l of Buffer A (50&nbsp;m<font size=-1>M</font> Hepes, pH 7.6,&nbsp;150&nbsp;m<font size=-1>M</font> NaCl, 1% Triton<SUP> </SUP>X-100, 10&nbsp;m<font size=-1>M</font> NaF, 20&nbsp;m<font size=-1>M</font> sodium pyrophosphate, 20&nbsp;m<font size=-1>M</font> <IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta ">-glycerol<SUP> </SUP>phosphate, 1&nbsp;m<font size=-1>M</font> sodium orthovanadate, 10&nbsp;&#181;g/ml
leupeptin, 10&nbsp;&#181;g/ml<SUP> </SUP>aprotinin, 1&nbsp;&#181;<font size=-1>M</font> microcystin-LR, and
1&nbsp;m<font size=-1>M</font> phenylmethylsulfonyl<SUP> </SUP>fluoride). The homogenate was
centrifuged (10,000&nbsp;&#215;&nbsp;<I>g</I>, 4&nbsp;&#176;C, 10<SUP>&nbsp;</SUP>min), and the
supernatants were used for immunoprecipitation or<SUP> </SUP>Western blot
experiments. For immunoprecipitation studies, cell<SUP> </SUP>lysates were
incubated with specific antibodies bound to protein<SUP> </SUP>G beads (Amersham
Pharmacia Biotech) for 4-6 h at 4&nbsp;&#176;C with gentle<SUP> </SUP>rotation. After
incubation, immunoprecipitates were washed extensively<SUP> </SUP>with ice-cold
Buffer B (50&nbsp;m<font size=-1>M</font> Hepes, pH 7.6,&nbsp;150&nbsp;m<font size=-1>M</font> NaCl, and<SUP> </SUP>0.1% Triton X-100). Proteins bound to the beads were eluted by<SUP> </SUP>heating
at 95&nbsp;&#176;C for 4&nbsp;min in SDS-PAGE sample loading buffer.<SUP> </SUP>The eluted
proteins were separated by SDS-PAGE, transferred to<SUP> </SUP>a nitrocellulose
membrane, and detected with specific antibodies.<SUP> </SUP>The expression of
various proteins was detected by Western blot<SUP> </SUP>of cell lysates with
antibodies specific to the Myc or FLAG-tag<SUP> </SUP>or to the protein.
Quantitation of the relative increase in PKB<SUP> </SUP>phosphorylation (expressed
as percentage of maximum phosphorylation)<SUP> </SUP>was performed by analyzing
Western blots using the National Institutes<SUP> </SUP>of Health IMAGE 1.58&nbsp;program and was normalized for the amount<SUP> </SUP>of PKB expression in each
experiment. All experiments were repeated<SUP> </SUP>independently at least three
times to ensure the consistency of<SUP> </SUP>the<SUP> </SUP>results.



    

    


<P><I>PDK1</A> Autophosphorylation--</I>

CHO/IR cells overexpressing
Myc-tagged wild-type PDK1</A>, PDK1<SUP>A280V</SUP>, or PH domain-deleted
mutants of PDK1</A> or PDK1<SUP>A280V</SUP> were serum-starved for 4&nbsp;h, treated with or without 10&nbsp;n<font size=-1>M</font> insulin<SUP> </SUP>for 5&nbsp;min, and
lysed in Buffer A.&nbsp;Cell lysates were centrifuged<SUP> </SUP>at 10,000&nbsp;&#215;&nbsp;<I>g</I> for 10&nbsp;min at 4&nbsp;&#176;C, and the proteins in the
supernatants<SUP> </SUP>were immunoprecipitated with antibody to the Myc-tag.
After washing<SUP> </SUP>the immunocomplexes twice with Buffer B and once with
Buffer C<SUP> </SUP>(50&nbsp;m<font size=-1>M</font> Tris-HCl, pH 7.5,&nbsp;5&nbsp;m<font size=-1>M</font>
MgCl<SUB>2</SUB>, 1&nbsp;m<font size=-1>M</font> Na<SUB>3</SUB>VO<SUB>4</SUB>, 1&nbsp;m<font size=-1>M</font> sodium<SUP> </SUP>pyrophosphate, 10&nbsp;m<font size=-1>M</font> NaF, and 1&nbsp;m<font size=-1>M</font> phenylmethylsulfonyl fluoride),<SUP> </SUP>autophosphorylation of
PDK1</A> was initiated with the addition of<SUP> </SUP>30&nbsp;&#181;l of Buffer C plus 2&nbsp;&#181;Ci of [<IMG SRC="/math/12pt/normal/gamma.gif" ALIGN=BASELINE ALT="gamma ">-<SUP>32</SUP>P]ATP and incubated for 10&nbsp;min at
30&nbsp;&#176;C. Bound proteins were eluted<SUP> </SUP>by heating at 95&nbsp;&#176;C for 4&nbsp;min
in SDS-PAGE sample buffer. Proteins<SUP> </SUP>were separated by SDS-PAGE and
blotted to a nitrocellulose membrane.<SUP> </SUP>Phosphorylation of PDK1</A> was
visualized by autoradiography and<SUP> </SUP>quantitated using the NIH IMAGE 1.58<SUP>&nbsp;</SUP>program.



    

    


<P><I>Confocal Immunofluorescence Microscopy--</I>

CHO/IR cells were
seeded in 24-well plates containing coverslips and transfected with
plasmids encoding Myc-tagged PDK1</A>, PDK1<SUP>A280V</SUP>, or the PH
domain-deleted mutant forms of PDK1</A> or PDK1<SUP>A280V</SUP> using
LipofectAMINE (Life Technologies). 24&nbsp;h after transfection,<SUP> </SUP>cells
were serum-starved for 1&nbsp;h, treated with or without 10&nbsp;n<font size=-1>M</font><SUP> </SUP>insulin for 10&nbsp;min, and then fixed in phosphate-buffered
saline<SUP> </SUP>containing 4% paraformaldehyde for 20&nbsp;min at room temperature.<SUP> </SUP>Fixed cells were permeabilized and blocked with phosphate-buffered<SUP> </SUP>saline containing 0.05% Triton X-100 and 10% normal goat serum.<SUP> </SUP>The
expression of Myc-tagged full-length or the PH domain-deleted<SUP> </SUP>mutants
of PDK1</A> or PDK1<SUP>A280V</SUP> was detected by incubation with the
anti-Myc-antibody, followed<SUP> </SUP>by a rhodamine-conjugated secondary
antibody (KPL). Images were<SUP> </SUP>captured by an Olympus Fluoview confocal
fluorescence<SUP> </SUP>microscope.



    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC2"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;RESULTS</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>RESULTS</FONT>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">DISCUSSION</A>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    



    



    


<P><I>Overexpression of PDK1<SUP>A280V</SUP> Is Sufficient to
Phosphorylate PKB at Thr<SUP>308</SUP> in Vivo--</I>

To characterize
the biochemical mechanism by which PKB is phosphorylated and activated
by PDK1</A>, we generated a mutant mouse<SUP> </SUP>PDK1</A> in which the alanine at
position 280&nbsp;was replaced with valine<SUP> </SUP>(PDK1<SUP>A280V</SUP>). Mutation
at the equivalent position in the <I>Caenorhabditis elegans</I><SUP> </SUP>homologue of mammalian PDK1</A> has been shown to increase PDK1</A> kinase<SUP> </SUP>activity and bypass the requirement for AGE1/PI3K in transducing<SUP> </SUP>upstream signals to PKB (<A HREF="#B16">16</A>). To test whether PDK1<SUP>A280V</SUP>
constitutively phosphorylated PKB in cells, we co-transfected<SUP> </SUP>CHO/IR
cells with PKB and either wild-type, A280V, or the kinase-defective<SUP> </SUP>mutant (PDK1<SUP>K114G</SUP> (<A HREF="#B13">13</A>)) of PDK1</A>. Western blot analysis
using phospho-specific<SUP> </SUP>antibodies directed against either
Thr<SUP>308</SUP> or Ser<SUP>473</SUP> of PKB showed little PKB
phosphorylation under basal conditions<SUP> </SUP>or in cells co-expressing
wild-type PDK1</A> or the kinase-defective<SUP> </SUP>mutant PDK1<SUP>K114G</SUP>
(Fig. <a href="#F1">1</a><I>A</I>, <I>top</I> and
<I>second panels</I>, <I>lanes 1</I>, <I>2</I>, and
<I>4</I>). On the other<SUP> </SUP>hand, co-expression of
PDK1<SUP>A280V</SUP> with PKB resulted in a marked increase in PKB
phosphorylation<SUP> </SUP>at Thr<SUP>308</SUP> to a level approximately equal to
that attained by insulin treatment<SUP> </SUP>(Fig. <a href="#F1">1</a><I>A</I>, <I>top
panel</I>, <I>lane 3&nbsp;versus lane 5</I>).
Concomitantly, a modest<SUP> </SUP>increase of phosphorylation at
Ser<SUP>473</SUP> was also observed (Fig. <a href="#F1">1</a><I>A</I>, <I>second
panel</I>, <I>lane 3&nbsp;versus 1</I>).
Overexpression<SUP> </SUP>of PDK1<SUP>A280V</SUP> did not stimulate the
phosphorylation of MAP kinase (data not<SUP> </SUP>shown).



<BR CLEAR=ALL><A NAME="F1"><!-- FIG 1 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/51/40400/F1">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=69 HEIGHT=200 SRC="/content/vol275/issue51/images/small/bc5209392001.gif"></A><BR>

<STRONG>View larger version</STRONG> (22K):
<BR><NOBR><A HREF="/cgi/content/full/275/51/40400/F1">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/51/40400/F1"
onClick="startTarget('F1', 302, 640); this.href='/cgi/content-nw/full/275/51/40400/F1'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F1">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 1. &nbsp;</STRONG>

<B>Overexpression of PDK1<SUP>A280V</SUP> is
sufficient to phosphorylate PKB at Thr<SUP>308</SUP> in CHO/IR
cells.</B> <I>A</I>, the effect of PDK1<SUP>A280V</SUP>
overexpression on PKB phosphorylation. Plasmid encoding Myc-PKB was
co-transfected into CHO/IR cells in 60-mm plates with various
constructs as indicated. Quiescent cells were stimulated with (+) or
without (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">) 10&nbsp;n<font size=-1>M</font> insulin for 5&nbsp;min and lysed in 120&nbsp;&#181;l
of lysis buffer. Cell lysates (8&nbsp;&#181;l) were directly analyzed for PKB
phosphorylation at Thr<SUP>308</SUP> (<I>top panel</I>) and
Ser<SUP>473</SUP> (<I>second panel</I>) using phospho-specific
antibodies. The expression of Myc-tagged PKB and PDK1</A> was confirmed by
Western blot using antibodies against PKB (<I>third panel</I>) and
PDK1</A> (<I>bottom panel</I>), respectively. <I>B</I>,
overexpression of PKN</A> and PRK2 inhibits PKB phosphorylation. CHO/IR
cells were transfected with various constructs as indicated. Quiescent
cells were stimulated with or without insulin and lysed as described in
<I>A</I>. Cell lysates were directly analyzed by Western blot using
antibodies against phospho-PKB-Thr<SUP>308</SUP> (<I>top
panel</I>), phospho-PKB-Ser<SUP>473</SUP> (<I>second panel</I>),
PKB (<I>third panel</I>), PDK1</A> (<I>fourth panel</I>), and FLAG
(<I>bottom panel</I>). <I>C</I>, effect of the AF3-PKN and the
PIF</A> fragment on PKB phosphorylation by PDK1<SUP>A280V</SUP>. CHO/IR
cells were co-transfected with various plasmids as indicated. Quiescent
cells were stimulated with or without insulin and lysed as described in
<I>A</I>. Cell lysates were analyzed by Western blot with
phospho-specific antibodies to PKB-Thr<SUP>308</SUP> (<I>top
panel</I>) or PKB-Ser<SUP>473</SUP> (<I>second panel</I>). The
expression of Myc-PKB, Myc-PDK1, FLAG-PKN-AF3, and GST-PIF was
confirmed by Western blot using antibodies to PKB (<I>third
panel</I>), PDK1</A> (<I>fourth panel</I>), FLAG (<I>fifth
panel</I>), or GST</A> (<I>bottom panel</I>), respectively. All
experiments were performed at least three times with similar
results.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 1 -->







    

    


<P><I>Overexpression of Full-length PRK1/PKN or PRK2 Inhibits
PDK1<SUP>A280V</SUP>-mediated PKB Phosphorylation--</I>

A recent study
has shown that PDK1</A> can phosphorylate Ser<SUP>473</SUP> of PKB upon
binding the PDK1-interactive fragment (PIF</A>) derived from<SUP> </SUP>PRK2 (<A HREF="#B7">7</A>). To
test whether PDK1<SUP>A280V</SUP> was able to phosphorylate PKB at
Ser<SUP>473</SUP>, we co-expressed Myc-tagged PKB and Myc-tagged
PDK1<SUP>A280V</SUP> in CHO/IR cells together with either FLAG-tagged
PRK2 or PRK1<SUP> </SUP>(also named PKN</A>), a PRK2-related protein that has recently
been<SUP> </SUP>found to interact with PDK1</A> in intact cells (<A HREF="#B17">17</A>). Our results<SUP> </SUP>showed that overexpression of PRK1/PKN significantly inhibited<SUP> </SUP>PDK1<SUP>A280V</SUP>-stimulated PKB phosphorylation at
Thr<SUP>308</SUP> (Fig. <a href="#F1">1</a><I>B</I>, <I>top panel</I>,
<I>lane 4&nbsp;versus lane 3</I>) and
Ser<SUP>473</SUP> (Fig. <a href="#F1">1</a><I>B</I>, <I>second panel</I>,
<I>lane 4&nbsp;versus lane 3</I>). A lesser
inhibition<SUP> </SUP>of PKB phosphorylation was observed in cells expressing PRK2
(Fig.<SUP> </SUP><a href="#F1">1</a><I>B</I>, top and <I>second panel</I>s, <I>lane
5&nbsp;versus lane 3</I>), probably due<SUP> </SUP>to lesser
expression of this protein compared with PKN</A> (Fig. <a href="#F1">1</a><I>B</I>,<SUP> </SUP><I>bottom panel</I>, <I>lane 5&nbsp;versus lane
4</I>). These findings suggest that<SUP> </SUP>full-length PKN</A> and PRK2 play
negative roles in PKB-mediated downstream<SUP> </SUP>events.
<P>
It is possible that the interaction of full-length PRK1/PKN or PRK2
with PDK1</A> induced a conformational change that was different<SUP> </SUP>from that
induced by the PIF</A> fragment. To test this possibility,<SUP> </SUP>we co-expressed
Myc-tagged PKB in CHO/IR cells together with either<SUP> </SUP>a control plasmid
(Fig. <a href="#F1">1</a><I>C</I>, <I>lanes 1</I>&nbsp;and <I>2</I>),
Myc-tagged PDK1<SUP>A280V</SUP> (Fig. <a href="#F1">1</a><I>C</I>, <I>lane
3</I>), Myc-tagged PDK1<SUP>A280V</SUP> plus the FLAG-tagged carboxyl
terminus of PRK1/PKN (AF3-PKN)<SUP> </SUP>(<A HREF="#B14">14</A>) (Fig. <a href="#F1">1</a><I>C</I>, <I>lane
4</I>), or Myc-tagged PDK1<SUP>A280V</SUP> plus the GST-PIF fusion
protein (Fig. <a href="#F1">1</a><I>C</I>, <I>lane 5</I>). Overexpression<SUP> </SUP>of
either AF3-PKN or GST-PIF had no significant effect on the<SUP> </SUP>expression
levels of PKB (Fig. <a href="#F1">1</a><I>C</I>, <I>third panel</I>) or PDK1</A>
(Fig.<SUP> </SUP><a href="#F1">1</a><I>C</I>, <I>fourth panel</I>). However, overexpression
of these proteins significantly<SUP> </SUP>inhibited PDK1<SUP>A280V</SUP>-induced
PKB phosphorylation at Thr<SUP>308</SUP> (Fig. <a href="#F1">1</a><I>C</I>,
<I>top panel</I>, <I>lane 3&nbsp;versus lane
4</I>&nbsp;or <I>5</I>). Although co-expression<SUP> </SUP>of
PDK1<SUP>A280V</SUP> and AF3-PKN did not significantly stimulate PKB
phosphorylation<SUP> </SUP>at Ser<SUP>473</SUP> (Fig. <a href="#F1">1</a><I>C</I>, <I>second
panel</I>, <I>lane 3&nbsp;versus lane 4</I>),
co-expression<SUP> </SUP>of PDK1<SUP>A280V</SUP> and the GST-PIF fusion protein
led to a 3-fold increase in the<SUP> </SUP>phosphorylation at this site (Fig.
<a href="#F1">1</a><I>C</I>, <I>second panel</I>, <I>lane 3&nbsp;versus<SUP> </SUP>lane 5</I>). These results are in agreement
with the recent finding<SUP> </SUP>that binding of PIF</A> fragment enables PDK1</A> to
phosphorylate PKB<SUP> </SUP>at Ser<SUP>473</SUP> (<A HREF="#B7">7</A>).



    

    


<P><I>Phosphorylation of PKB at Thr<SUP>308</SUP> by
PDK1<SUP>A280V</SUP> Is Independent of PI3K</A> Activation--</I>

To test
whether PI3K</A> is required for PDK1<SUP>A280V</SUP>-mediated
phosphorylation of PKB, we co-transfected PKB into CHO/IR cells
together<SUP> </SUP>with either a pcDNA control plasmid or a plasmid encoding
PDK1<SUP>A280V</SUP> and examined PKB phosphorylation in the presence
or absence of<SUP> </SUP>PI3K</A> inhibitors. In the absence of PDK1<SUP>A280V</SUP>,
insulin treatment led to a significant increase in PKB phosphorylation<SUP> </SUP>at Thr<SUP>308</SUP> (Fig.
<a href="#F2">2</a><I>A</I>, <I>top panel</I>,
<I>lane 1&nbsp;versus lane 2</I>). This
insulin-stimulated<SUP> </SUP>phosphorylation of PKB at Thr<SUP>308</SUP> was
blocked by either wortmannin (Fig. <a href="#F2">2</a><I>A</I>, <I>top panel</I>,
<I>lane 3</I>)<SUP> </SUP>or LY294002 (Fig. <a href="#F2">2</a><I>A</I>, <I>top
panel</I>, <I>lane 4</I>). In agreement with our<SUP> </SUP>earlier findings
(Fig. <a href="#F1">1</a><I>A</I>, <I>top panel</I>), co-expression of
PDK1<SUP>A280V</SUP> with PKB resulted in a marked increase in PKB
phosphorylation<SUP> </SUP>at Thr<SUP>308</SUP> (Fig. <a href="#F2">2</a><I>A</I>, <I>top
panel</I>, <I>lane 5</I>), which was only slightly enhanced<SUP> </SUP>after
insulin treatment (Fig. <a href="#F2">2</a><I>A</I>, <I>top panel</I>, <I>lane
6</I>). However,<SUP> </SUP>neither wortmannin nor LY294002 inhibited the
PDK1<SUP>A280V</SUP>-stimulated PKB phosphorylation at
Thr<SUP>308</SUP> (Fig. <a href="#F2">2</a><I>A</I>, <I>top panel</I>,
<I>lane 5&nbsp;versus lanes 7</I>&nbsp;or
<I>8</I>).



<BR CLEAR=ALL><A NAME="F2"><!-- FIG 2 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/51/40400/F2">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=125 HEIGHT=200 SRC="/content/vol275/issue51/images/small/bc5209392002.gif"></A><BR>

<STRONG>View larger version</STRONG> (29K):
<BR><NOBR><A HREF="/cgi/content/full/275/51/40400/F2">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/51/40400/F2"
onClick="startTarget('F2', 425, 640); this.href='/cgi/content-nw/full/275/51/40400/F2'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F2">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 2. &nbsp;</STRONG>

<B>Phosphorylation of PKB by
PDK1<SUP>A280V</SUP> is insensitive to </B><B>PI3K</B></A><B> inhibitors and
ceramide.</B> <I>A</I>, overexpression of PDK1<SUP>A280V</SUP>
prevents wortmannin- or LY294002-induced inhibition of PKB
phosphorylation at Thr<SUP>308</SUP>. Quiescent CHO/IR cells
co-expressing Myc-tagged PKB and either PDK1</A> or PDK1<SUP>A280V</SUP>
were left untreated (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">) or treated (+) with 50&nbsp;&#181;<font size=-1>M</font>
LY294002 or 50&nbsp;n<font size=-1>M</font> wortmannin for 1&nbsp;h, followed by
treatment with 10&nbsp;n<font size=-1>M</font> insulin for 8&nbsp;min. Cells were lysed in
120&nbsp;&#181;l of lysis buffer, and cell lysates were analyzed by Western
blot using antibodies to phospho-Thr<SUP>308</SUP> of PKB (<I>top
panel</I>), PKB (<I>middle panel</I>), or PDK1</A> (<I>bottom
panel</I>). <I>B</I>, overexpression of PDK1<SUP>A280V</SUP>
prevents ceramide-induced inhibition of PKB phosphorylation. PKB was
co-expressed in CHO/IR cells with a control plasmid (pcDNA)
(<I>lanes 1-3</I>), wild-type PDK1</A> (<I>lanes 4-6</I>), or
PDK1<SUP>A280V</SUP> (<I>lanes 7-9</I>). Quiescent cells were
treated with increasing concentrations of ceramide as indicated, and
then with (+) or without (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">) 10&nbsp;n<font size=-1>M</font> insulin for 8&nbsp;min. Cell
lysates were analyzed by Western blot with antibodies to
phospho-PKB-Thr<SUP>308</SUP> (<I>top panel</I>),
phospho-PKB-Ser<SUP>473</SUP> (<I>second panel</I>), PKB
(<I>third panel</I>), and PDK1</A> (<I>bottom panel</I>). Data are
representative of three individual experiments with similar
results.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 2 -->







    

    


<P><I>Overexpression of PDK1<SUP>A280V</SUP> Prevents Ceramide-induced
Inhibition of PKB Phosphorylation--</I>

To further understand the
mechanism of PKB phosphorylation, we investigated the phosphorylation
of PKB by PDK1</A> in the presence<SUP> </SUP>or absence of C<SUB>2</SUB>-ceramide, a
cell-permeable reagent that indirectly<SUP> </SUP>inhibits PKB phosphorylation and
activity (<A HREF="#B12">12</A>). Consistent with<SUP> </SUP>the results of others (<A HREF="#B18">18</A>, <A HREF="#B19">19</A>), we found
that treatment of<SUP> </SUP>CHO/IR cells with ceramide inhibited PKB
phosphorylation at both<SUP> </SUP>Thr<SUP>308</SUP> (Fig. <a href="#F2">2</a><I>B</I>,
<I>top panel</I>, <I>lane 1&nbsp;versus lanes
2</I>&nbsp;and <I>3</I>) and Ser<SUP>473</SUP> (Fig. <a href="#F2">2</a><I>B</I>,
<I>second panel</I>, <I>lane 1&nbsp;versus
lanes 2</I>&nbsp;and <I>3</I>) but had<SUP> </SUP>no significant
effect on the autophosphorylation of the IR</A> and<SUP> </SUP>the tyrosine
phosphorylation of IR</A> substrate-1 (IRS-1) (data not<SUP> </SUP>shown). The
inhibition of PKB phosphorylation by ceramide was<SUP> </SUP>partially prevented
by overexpression of wild-type PDK1</A> and almost<SUP> </SUP>completely blocked by
overexpression of PDK1<SUP>A280V</SUP> (Fig. <a href="#F2">2</a><I>B</I>, <I>top
panel</I>, <I>lanes 4-9</I>). In addition, we have found that<SUP> </SUP>ceramide did not inhibit PDK1</A> activity <I>in vitro</I> (data not<SUP> </SUP>shown).



    

    


<P><I>Phosphorylation at Thr<SUP>308</SUP> and the Kinase Activity of
PKB Are Important for PKB Phosphorylation at
Ser<SUP>473</SUP>--</I>

It has recently been shown that
phosphorylation by PDK1</A> <I>in vitro</I> triggers the
phosphorylation at Ser<SUP>473</SUP> in kinase-active, but not
thermally inactivated PKB (<A HREF="#B8">8</A>). To<SUP> </SUP>test whether phosphorylation of PKB
at Thr<SUP>308</SUP> is sufficient to initiate the phosphorylation of
PKB at Ser<SUP>473</SUP> in intact cells, we co-expressed Myc-tagged
wild-type PKB, PKB<SUP>T308A</SUP>, or a kinase-inactive
PKB<SUP>K179A</SUP> in CHO/IR cells together with either a control
plasmid or Myc-tagged<SUP> </SUP>PDK1<SUP>A280V</SUP>. Cells were treated with or
without insulin, and the phosphorylation<SUP> </SUP>of PKB at Thr<SUP>308</SUP>
and Ser<SUP>473</SUP> was examined. Stimulation of cells with insulin
(Fig. <a href="#F3">3</a>, <I>top<SUP> </SUP>panel</I>, <I>lane
1&nbsp;versus lane 2</I>) or overexpression of
PDK1<SUP>A280V</SUP> (Fig. <a href="#F3">3</a>, <I>top panel</I>, <I>lane 1&nbsp;versus lane 3</I>). led to a marked increase<SUP> </SUP>in the
phosphorylation at Thr<SUP>308</SUP> of wild-type PKB. As expected,
the PKB<SUP>T308A</SUP> mutant was not phosphorylated in the
activation loop under these<SUP> </SUP>conditions (Fig. <a href="#F3">3</a>, <I>top panel</I>,
<I>lanes 4-6</I>). Inactivation of the<SUP> </SUP>kinase by
replacing the ATP-binding site lysine residue (Lys<SUP>179</SUP>) with
alanine resulted in a 70% decrease in the insulin- or
PDK1<SUP>A280V</SUP>-stimulated phosphorylation at Thr<SUP>308</SUP>
(Fig. <a href="#F3">3</a>, <I>top panel</I>, <I>lanes 2</I>&nbsp;and
<I>3&nbsp;versus 8</I>&nbsp;and <I>9</I>). However,
replacing<SUP> </SUP>Ser<SUP>473</SUP> with alanine had essentially no effect on
PKB phosphorylation<SUP> </SUP>at Thr<SUP>308</SUP> (data not shown). Consistent
with the findings of others (<A HREF="#B8">8</A>),<SUP> </SUP>a mutation at Thr<SUP>308</SUP>
inhibited the insulin-stimulated phosphorylation at Ser<SUP>473</SUP>
(Fig. <a href="#F3">3</a>, <I>second panel</I>, <I>lane 5</I>). Inactivation of
PKB also resulted<SUP> </SUP>in a marked decrease in the insulin-stimulated PKB
phosphorylation<SUP> </SUP>at Ser<SUP>473</SUP> (Fig. <a href="#F3">3</a>, <I>second panel</I>,
<I>lane 2&nbsp;versus lane 8</I>). However,
quantitation<SUP> </SUP>analysis revealed that approximately 46% of
Ser<SUP>473</SUP> phosphorylation remained for this kinase-inactive
mutant. Together,<SUP> </SUP>these finding suggest that phosphorylation at
Thr<SUP>308</SUP> and the kinase activity of PKB play an important
role in the<SUP> </SUP>phosphorylation of the enzyme at Ser<SUP>473</SUP>.
However, because PKB<SUP>K179A</SUP> was still able to undergo
insulin-stimulated phosphorylation<SUP> </SUP>at Ser<SUP>473</SUP> in cells, a
mechanism other than or in addition to autophosphorylation<SUP> </SUP>may play a
role in the insulin-stimulated phosphorylation of PKB<SUP> </SUP>at this site.



<BR CLEAR=ALL><A NAME="F3"><!-- FIG 3 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/51/40400/F3">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=200 HEIGHT=154 SRC="/content/vol275/issue51/images/small/bc5209392003.gif"></A><BR>

<STRONG>View larger version</STRONG> (34K):
<BR><NOBR><A HREF="/cgi/content/full/275/51/40400/F3">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/51/40400/F3"
onClick="startTarget('F3', 590, 539); this.href='/cgi/content-nw/full/275/51/40400/F3'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F3">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 3. &nbsp;</STRONG>

<B>Mutation at Thr<SUP>308</SUP> or
inactivation of kinase activity affects PKB phosphorylation at
Ser<SUP>473</SUP>.</B> Myc-tagged wild-type (<I>lanes 1-3</I>),
T308A (<I>lanes 4-6</I>), or K179A (<I>lanes
7-9</I>) mutants of PKB were co-transfected with pcDNA (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">)
or Myc-tagged PDK1<SUP>A280V</SUP> (+) into CHO/IR cells. Quiescent
cells were left untreated (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">) or treated with (+) 10&nbsp;n<font size=-1>M</font>
insulin for 5&nbsp;min. Cell lysates (1/20 of total) were analyzed by
Western blot with antibodies to phospho-PKB-Thr<SUP>308</SUP>
(<I>top panel</I>), phospho-PKB-Ser<SUP>473</SUP> (<I>second
panel</I>), PKB (<I>third panel</I>), and PDK1</A> (<I>bottom
panel</I>). Data are representative of three independent experiments
with similar results.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 3 -->







    

    


<P><I>The PH Domain of PKB Is Not Essential for
PDK1<SUP>A280V</SUP>-catalyzed Phosphorylation of PKB at
Thr<SUP>308</SUP>--</I>

To test whether the PH domain of PKB is
required for PDK1<SUP>A280V</SUP>-catalyzed phosphorylation of PKB, we
co-transfected CHO/IR cells<SUP> </SUP>with PDK1<SUP>A280V</SUP> and either the
wild-type or a PKB mutant in which the PH domain<SUP> </SUP>(residues 1-102) was
deleted. Western blot studies showed that<SUP> </SUP>insulin treatment led to an
increase in PKB phosphorylation at<SUP> </SUP>Thr<SUP>308</SUP> (Fig.
<a href="#F4">4</a><I>A</I>, <I>top panel</I>,
<I>lane 1&nbsp;versus lane 2</I>). This
insulin-stimulated<SUP> </SUP>phosphorylation was abolished for the PH
domain-deleted mutant<SUP> </SUP>PKB(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) (Fig. <a href="#F4">4</a><I>A</I>, <I>top
panel</I>, <I>lane 5</I>). On the other hand, only<SUP> </SUP>a partial
inhibition of the PDK1<SUP>A280V</SUP>-mediated phosphorylation was
observed for PKB(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) compared with<SUP> </SUP>that of the full-length enzyme
(Fig. <a href="#F4">4</a><I>A</I>, <I>top panel</I>, <I>lane 3&nbsp;versus<SUP> </SUP>lane 6</I>). Because the PH domain of PKB has
been shown to be necessary<SUP> </SUP>for the translocation of the enzyme to the
plasma membrane (<A HREF="#B1">1</A>),<SUP> </SUP>our findings suggest that PDK1<SUP>A280V</SUP> is
able to phosphorylate PKB(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) in the cytosol. This is also<SUP> </SUP>consistent with our earlier finding that treatment of cells with<SUP> </SUP>PI3K</A>
inhibitors did not block PDK1<SUP>A280V</SUP>-mediated phosphorylation
of PKB (Fig. <a href="#F2">2</a><I>A</I>).



<BR CLEAR=ALL><A NAME="F4"><!-- FIG 4 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/51/40400/F4">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=89 HEIGHT=200 SRC="/content/vol275/issue51/images/small/bc5209392004.gif"></A><BR>

<STRONG>View larger version</STRONG> (25K):
<BR><NOBR><A HREF="/cgi/content/full/275/51/40400/F4">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/51/40400/F4"
onClick="startTarget('F4', 346, 640); this.href='/cgi/content-nw/full/275/51/40400/F4'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F4">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 4. &nbsp;</STRONG>

<B>The PH domain of PDK1<SUP>A280V</SUP> is
necessary for phosphorylation of PKB in cells.</B> A, deletion of the
PH domain of PKB does not affect PDK1<SUP>A280V</SUP>-mediated
phosphorylation of PKB at Thr<SUP>308</SUP>. FLAG-tagged wild-type
(<I>lanes 1-3</I>) or <IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH (<I>lanes 4-6</I>) PKB was
co-transfected into CHO/IR cells with (+) or without (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">)
PDK1<SUP>A280V</SUP>. Quiescent cells were left untreated (<IMG SRC="/math/12pt/normal/minus.gif" ALIGN=BASELINE ALT="-">) or
treated (+) with 10&nbsp;n<font size=-1>M</font> insulin for 5&nbsp;min. Cell lysates were
analyzed by Western blot using antibodies specific to
phospho-PKB-Thr<SUP>308</SUP> (<I>top panel</I>), PKB
(<I>middle panel</I>), and PDK1</A> (<I>bottom panel</I>).
<I>B</I>, deletion of the PH domain of PDK1</A> or
PDK1<SUP>A280V</SUP> inhibits PKB phosphorylation at
Thr<SUP>308</SUP>. CHO/IR cells were co-transfected with wild-type PKB
and either PDK1</A>, PDK1</A>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH), PDK1<SUP>A280V</SUP>, or
PDK1<SUP>A280V</SUP>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH). Cells were treated with or without
insulin as described in <I>A</I>. Cell lysates were analyzed by
Western blot with antibodies to phospho-PKB-Thr<SUP>308</SUP>
(<I>top panel</I>), PKB (<I>middle panel</I>), and PDK1</A>
(<I>bottom panel</I>). Results shown in <I>A</I> and
<I>B</I> are representative of at least three independent
experiments with similar results. <I>C</I>, autophosphorylation of
wild-type and PH-domain-deleted mutants of PDK1</A> or
PDK1<SUP>A280V</SUP> <I>in vitro</I>. Myc-tagged wild-type and PH
domain-deleted mutants of PDK1</A> and PDK1<SUP>A280V</SUP> were
immunoprecipitated from CHO/IR cells overexpressing these proteins
using an antibody against the tag. Autophosphorylation of PDK1</A> was
carried out as described under "Experimental Procedures." The
phosphorylation of PDK1</A> was visualized by autoradiography and
quantified by the NIH IMAGE program. Equal expression of PKB in each
sample was determined by Western blot analysis of cell lysates with
antibody to the Myc-tag. The mean percentage of maximal
phosphorylation&nbsp;&#177;&nbsp;S.D. from two independent experiments is
shown.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 4 -->







    

    


<P><I>Deletion of the PH Domain of PDK1<SUP>A280V</SUP> Inhibits
PDK1<SUP>A280V</SUP>-catalyzed Phosphorylation of PKB at
Thr<SUP>308</SUP>--</I>

The PH domain of PDK1</A> has been shown to bind
phosphoinositides and be necessary for PDK1-mediated phosphorylation
and activation<SUP> </SUP>of PKB (<A HREF="#B20">20</A>, <A HREF="#B21">21</A>). To test whether the PH domain is
required<SUP> </SUP>for PDK1<SUP>A280V</SUP>-mediated phosphorylation of PKB at
Thr<SUP>308</SUP>, we generated mutants of PDK1</A> and
PDK1<SUP>A280V</SUP> in which the PH domains were deleted.
Co-expression of PKB with<SUP> </SUP>wild-type PDK1</A> or PDK1</A>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) had no
significant effect on basal<SUP> </SUP>PKB phosphorylation at Thr<SUP>308</SUP>
(Fig. <a href="#F4">4</a><I>B</I>, <I>top panel</I>, <I>lanes
1</I>&nbsp;and <I>2</I>). Conversely, co-expression<SUP> </SUP>of
PDK1<SUP>A280V</SUP> with PKB markedly increased the phosphorylation
of PKB at this<SUP> </SUP>site (Fig. <a href="#F4">4</a><I>B</I>, <I>top panel</I>,
<I>lane 3</I>). The PDK1<SUP>A280V</SUP>-stimulated
phosphorylation of PKB at Thr<SUP>308</SUP> was markedly decreased by
deletion of the PH domain of PDK1<SUP>A280V</SUP> (Fig. <a href="#F4">4</a><I>B</I>,
<I>top panel</I>, <I>lane 3&nbsp;versus lane
4</I>). In addition, overexpression<SUP> </SUP>of the PDK1</A>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) or
PDK1<SUP>A280V</SUP>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) inhibited insulin-stimulated
phosphorylation of PKB at Thr<SUP>308</SUP> (Fig. <a href="#F4">4</a><I>B</I>,
<I>top panel</I>, <I>lane 5&nbsp;versus 6</I>&nbsp;and <I>lane 7&nbsp;versus 8</I>). These<SUP> </SUP>findings
indicate that the PH domain of PDK1</A> is important for<SUP> </SUP>the enzyme to
interact with and phosphorylate PKB in<SUP> </SUP>cells.
<P>
One explanation for the inhibition of PKB phosphorylation by
PDK1</A>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) or PDK1<SUP>A280V</SUP>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) might be that removal of
the PH domain rendered the enzyme<SUP> </SUP>inactive. To test this possibility,
we examined the autophosphorylation<SUP> </SUP>of wild-type and PH domain-deleted
mutants of PDK1</A> and PDK1<SUP>A280V</SUP>. Wild-type PDK1</A> and
PDK1<SUP>A280V</SUP> isolated from both serum-starved and
insulin-treated cells were<SUP> </SUP>autophosphorylated <I>in vitro</I> (Fig.
<a href="#F4">4</a><I>C</I>). Deletion of the PH domain<SUP> </SUP>or replacing alanine at 280&nbsp;with valine led to approximately a<SUP> </SUP>2-&nbsp;and 3-fold increase in the
autophosphorylation of PDK1</A>, respectively.<SUP> </SUP>However, deletion of the PH
domain did not further stimulate the<SUP> </SUP>autokinase activity of
PDK1<SUP>A280V</SUP> (Fig. <a href="#F4">4</a><I>C</I>). Therefore, deletion of the
PH domain increased, rather<SUP> </SUP>than inhibited, PDK1</A> catalytic activity
<I>per se</I>.



    

    


<P><I>Deletion of the PH Domain of PDK1<SUP>A280V</SUP> Prevents Its
Plasma Membrane Translocation--</I>

The finding that deletion of the PH
domain did not affect PDK1<SUP>A280V</SUP> autophosphorylation
<I>in vitro</I> but prevented the enzyme from phosphorylating<SUP> </SUP>PKB
in cells suggested that the PH domain plays a role in the<SUP> </SUP>interaction
of PDK1<SUP>A280V</SUP> with its substrates. To test this idea, we
examined the cellular<SUP> </SUP>localization of PDK1</A>, PDK1<SUP>A280V</SUP>, and
their PH-domain-deleted mutants by confocal immunofluorescence<SUP> </SUP>studies.
In unstimulated CHO/IR cells, PDK1<SUP>A280V</SUP> localized both at
the plasma membrane and in the cytosol in a<SUP> </SUP>punctate manner (Fig.
<a href="#F5">5</a>, <I>a</I> and <I>b</I>). Plasma
membrane association<SUP> </SUP>of PDK1<SUP>A280V</SUP> was also observed in
cells treated with insulin (Fig. <a href="#F5">5</a>, <I>c</I> and<SUP> </SUP><I>d</I>). On
the other hand, no significant plasma membrane immunofluorescence<SUP> </SUP>staining was observed for PDK1<SUP>A280V</SUP>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) before or after
insulin treatment (Fig. <a href="#F5">5</a>, <I>e-h</I>). Under serum-starved<SUP> </SUP>conditions, wild-type PDK1</A> (Fig. <a href="#F5">5</a>, <I>i</I> and <I>j</I>) and
PDK1</A>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) (Fig.<SUP> </SUP><a href="#F5">5</a>, <I>m</I> and <I>n</I>) resided
predominantly in the perinuclear region. Although<SUP> </SUP>insulin treatment led
to a decrease in the perinuclear staining<SUP> </SUP>of the wild-type PDK1</A> (Fig.
<a href="#F5">5</a>, <I>k</I> and <I>l</I>), it had no significant<SUP> </SUP>effect on the
intracellular translocation of PDK1</A>(<IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH) (Fig. <a href="#F5">5</a>,<SUP> </SUP><I>o</I> and
<I>p</I>). These findings are consistent with an earlier report<SUP> </SUP>that the PH domain is important for PDK1</A> translocation to the<SUP> </SUP>plasma
membrane (<A HREF="#B20">20</A>).



<BR CLEAR=ALL><A NAME="F5"><!-- FIG 5 --></A>

<P><CENTER><BR CLEAR=ALL><TABLE BORDER WIDTH=95% CELLPADDING=0 CELLSPACING=0><TR BGCOLOR=E1E1E1><TD>
<TABLE CELLPADDING=2 CELLSPACING=2><TR BGCOLOR=E1E1E1>
<TD ALIGN=CENTER VALIGN=TOP BGCOLOR=FFFFFF>

<A HREF="/cgi/content/full/275/51/40400/F5">
<IMG HSPACE=10 VSPACE=5 BORDER=2 WIDTH=192 HEIGHT=200 SRC="/content/vol275/issue51/images/small/bc5209392005.gif"></A><BR>

<STRONG>View larger version</STRONG> (97K):
<BR><NOBR><A HREF="/cgi/content/full/275/51/40400/F5">[in this window]</A>
<BR><A HREF="/cgi/content-nw/full/275/51/40400/F5"
onClick="startTarget('F5', 572, 640); this.href='/cgi/content-nw/full/275/51/40400/F5'"
    onMouseOver="window.status='View figure in a separate window'; return true"
    TARGET="F5">[in a new window]</A><BR>&nbsp;
</NOBR>
</TD><TD ALIGN=LEFT VALIGN=TOP>

<STRONG>Fig. 5. &nbsp;</STRONG>

<B>The PH domain is important for </B><B>PDK1</B></A><B>
subcellular localization.</B> CHO/IR cells expressing
Myc-tagged full-length PDK1</A> or PDK1<SUP>A280V</SUP> or the PH
domain-deleted mutants of these enzymes were serum-starved for 1&nbsp;h
and treated with or without 10&nbsp;n<font size=-1>M</font> insulin for 10&nbsp;min. Cells
were then fixed and labeled with the anti-Myc antibody, followed by
rhodamine-labeled second antibody. The confocal images presented here
represent projections of Z-series scans. Representative fields are
shown of immunofluorescence (<I>anti-Myc</I>) and the corresponding
differential interference contrast (<I>DIC</I>) images. Data are
representative of three independent experiments with similar
results.


<BR CLEAR=LEFT>

</TD></TR></TABLE>
</TD></TR></TABLE>
</CENTER>
<!-- /FIG 5 -->







    


    


    
    


<BR><BR CLEAR=ALL>


<A NAME="SEC3"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;DISCUSSION</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>DISCUSSION</FONT>


<BR>
<A HREF="#References"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/darrow.gif">REFERENCES</A>
</FONT></TH>
</TR></TABLE>


    
    <P>Phosphorylation of PKB at Thr<SUP>308</SUP> in the activation
loop by PDK1</A> is considered essential for PKB activation. However, the
biochemical<SUP> </SUP>and cellular mechanisms by which PKB is phosphorylated by
upstream<SUP> </SUP>kinases remain<SUP> </SUP>unclear.
    
    </P>

    
    <P>In the present studies, we have examined the biochemical mechanism of
PKB phosphorylation by using a constitutively active<SUP> </SUP>mutant of PDK1</A>.
Expression of the gain-of-function mutant PDK1</A><SUP> </SUP>homologue has recently
been shown to bypass the requirement for<SUP> </SUP>AGE-1/PI3K-mediated
PtdIns</A>(3,4)P<SUB>2</SUB> and PtdIns</A>(3,4,5)P<SUB>3</SUB> production<SUP> </SUP>to
induce dauer arrest in <I>C.&nbsp;elegans</I> (<A HREF="#B16">16</A>). In agreement
with<SUP> </SUP>this finding, we have found that expression of
PDK1<SUP>A280V</SUP> was sufficient to induce significant
phosphorylation of PKB at<SUP> </SUP>Thr<SUP>308</SUP> in intact cells (Fig.
<a href="#F1">1</a><I>A</I>). Pretreatment of cells with either<SUP> </SUP>LY294002 or
wortmannin, or deletion of the PH domain of PKB, had<SUP> </SUP>essentially no
effect on PDK1<SUP>A280V</SUP>-mediated phosphorylation of PKB at
Thr<SUP>308</SUP> (Figs. <a href="#F2">2</a><I>A</I> and <a href="#F4">4</a><I>A</I>). These
findings suggest that activation of<SUP> </SUP>PDK1</A> is sufficient to phosphorylate
PKB at Thr<SUP>308</SUP> in the cytosol. This is consistent with an
earlier finding that<SUP> </SUP>a PKB mutant lacking its PH domain could be
activated by either<SUP> </SUP>insulin or PDGF in several cell types (<A HREF="#B11">11</A>). More
recently, it<SUP> </SUP>has been found that insulin stimulates an increase of
PKB<IMG SRC="/math/12pt/normal/beta.gif" ALIGN=BASELINE ALT="beta "> phosphorylation<SUP> </SUP>in the cytosol (<A HREF="#B22">22</A>). Consistently, PDK1</A> has been
found both<SUP> </SUP>at the plasma membrane and in the cytosol (<A HREF="#B20">20</A>, <A HREF="#B21">21</A>).
    
    </P>

    
    <P>While this manuscript was under revision, Filippa <I>et al.</I>
(<A HREF="#B23">23</A>) reported that overexpression of <IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH-PDK1 activated <IMG SRC="/math/12pt/normal/Delta.gif" ALIGN=BASELINE ALT="Delta ">PH-PKB<SUP> </SUP>in
293&nbsp;cells. Based on this finding, they suggest that the PH<SUP> </SUP>domain of
PDK1</A> acts as a negative regulator of its enzyme activity.<SUP> </SUP>In agreement
with their results, we have found that deletion of<SUP> </SUP>the PH domain
stimulated PDK1</A> autokinase activity <I>in vitro</I> (Fig.<SUP> </SUP><a href="#F4">4</a><I>C</I>). However, our results also show that the PH domain of
PDK1</A><SUP> </SUP>is necessary for PDK1-mediated PKB phosphorylation in cells,
because<SUP> </SUP>overexpression of the PH-domain-deleted mutants of PDK1</A> or
PDK1<SUP>A280V</SUP> inhibited phosphorylation of full-length PKB
(Fig. <a href="#F4">4</a><I>B</I>). These<SUP> </SUP>findings suggest the PH domain plays a dual
role in regulating<SUP> </SUP>PDK1</A> activity in cells. On one hand, the PH domain
may be necessary<SUP> </SUP>for targeting the enzyme to a specific cellular
location to interact<SUP> </SUP>with and phosphorylate its substrates. On the
other hand, this<SUP> </SUP>domain may function as an autoinhibitory region to
block the catalytic<SUP> </SUP>activity of PDK1</A> under basal conditions. This
inhibitory mechanism<SUP> </SUP>may be important for preventing nonspecific
phosphorylation and<SUP> </SUP>activation of PDK1</A> downstream substrates under
non-stimulatory<SUP> </SUP>conditions. After growth factor stimulation, the
binding of phospholipids<SUP> </SUP>to the PH domain may induce a conformational
change that relieves<SUP> </SUP>the inhibitory blockage so that PDK1</A> becomes fully
active. In<SUP> </SUP>addition to activating PDK1</A>, the binding of phospholipids
may<SUP> </SUP>also promote the plasma membrane translocation of the enzyme.<SUP> </SUP>Thus,
the PH domain may function as a switch to regulate PDK1-mediated<SUP> </SUP>biological events in<SUP> </SUP>cells.
    
    </P>

    
    <P>Until recently, it has been suggested that PDK1</A> is constitutively
active in cells and that phosphorylation and activation<SUP> </SUP>of its
downstream substrates is mediated mainly by translocation<SUP> </SUP>and
conformational changes of its substrates (<A HREF="#B24">24</A>, <A HREF="#B25">25</A>). However,<SUP> </SUP>our data
suggest that PDK1</A> can be activated above its basal level<SUP> </SUP>both <I>in
vitro</I> and in cells. Consistent with this, a mutation at<SUP> </SUP>Ala<SUP>280</SUP> or deletion of the PH domain significantly increased
PDK1</A> autophosphorylation<SUP> </SUP><I>in vitro</I> (Fig. <a href="#F4">4</a><I>C</I>). In
addition, overexpression of PDK1<SUP>A280V</SUP>, but not wild-type
PDK1</A>, was able to phosphorylate PKB at Thr<SUP>308</SUP> to the same
extent as that stimulated by insulin (Fig. <a href="#F1">1</a><I>A</I>). Thus,<SUP> </SUP>although PDK1</A> is constitutively active <I>in vitro</I>, its
activation<SUP> </SUP>may be tightly regulated in cells. This idea is consistent
with<SUP> </SUP>a recent finding that PDK1</A> is activated by sphingosine both
<I>in<SUP> </SUP>vitro</I> and <I>in vivo</I> (<A HREF="#B26">26</A>). Moreover, it has also
recently been<SUP> </SUP>shown that treatment of cells with the phosphatase
inhibitors<SUP> </SUP>okadaic acid and calyculin A inhibited PKB
phosphorylation at<SUP> </SUP>Thr<SUP>308</SUP> (<A HREF="#B27">27</A>), suggesting that
phosphorylation plays a role in regulating<SUP> </SUP>PDK1</A> activity in cells.
Consistent with the findings of others<SUP> </SUP>(<A HREF="#B28">28</A>), we have found that
phosphorylation of Ser<SUP>244</SUP> in the activation loop of mouse
PDK1</A> is essential for the
autophosphorylation<SUP> </SUP>and kinase activity of the
enzyme.<A HREF="#FN2"><SUP>2</SUP></A>
    
    </P>

    
    <P>Ceramide has been shown to be a potent inhibitor for PKB
phosphorylation in cells (<A HREF="#B18">18</A>, <A HREF="#B19">19</A>). Because C<SUB>2</SUB>-ceramide does
not<SUP> </SUP>inhibit insulin-stimulated PI3K</A> activation in cells and has no<SUP> </SUP>effect on PKB catalytic activity <I>in vitro</I>, it has been
hypothesized<SUP> </SUP>that its action may be due to the inhibition of an
immediate upstream<SUP> </SUP>kinase for PKB (<A HREF="#B12">12</A>). However, our data showed that
ceramide-induced<SUP> </SUP>inhibition could be blocked by PDK1<SUP>A280V</SUP>
(Fig. <a href="#F2">2</a><I>B</I>). In addition, ceramide did not inhibit PDK1</A>
activity<SUP> </SUP><I>in vitro</I> (data not shown). These findings suggest
that the inhibition<SUP> </SUP>of PKB by ceramide is not mediated by direct
inhibition of PDK1</A>.<SUP> </SUP>These results are consistent with the findings that
the inhibition<SUP> </SUP>of PKB phosphorylation by ceramide in cells is due to
the activation<SUP> </SUP>of a protein phosphatase (<A HREF="#B27">27</A>, <A HREF="#B29">29</A>) rather than by the
inhibition<SUP> </SUP>of the PKB upstream kinase PDK1</A>.
    
    </P>

    
    <P>It has recently been suggested that phosphorylation of PKB at the PDK2
site is mediated by autophosphorylation (<A HREF="#B8">8</A>). This<SUP> </SUP>conclusion is
supported by the findings that incubation of purified<SUP> </SUP>PKB with PDK1</A> led
to phosphorylation at both Thr<SUP>308</SUP> and Ser<SUP>473</SUP>,
and phosphorylation at Ser<SUP>473</SUP> requires prior
phosphorylation at Thr<SUP>308</SUP> and the intrinsic catalytic
activity of the enzyme (<A HREF="#B8">8</A>). However,<SUP> </SUP>whether phosphorylation of PKB at
Thr<SUP>308</SUP> is sufficient to trigger autophosphorylation at
Ser<SUP>473</SUP> in intact cells is unknown. In our studies, we found
that expression<SUP> </SUP>of a constitutively active PDK1</A> induced marked
phosphorylation<SUP> </SUP>of PKB at Thr<SUP>308</SUP> and to a lesser extent
Ser<SUP>473</SUP> (Fig. <a href="#F1">1</a>). Because PDK1</A> does not directly
phosphorylate PKB at<SUP> </SUP>Ser<SUP>473</SUP>, these findings suggest that
phosphorylation of Thr<SUP>308</SUP> by PDK1</A> is able to induce PKB
autophosphorylation at Ser<SUP>473</SUP>. This idea is consistent with
a recent finding that phosphorylation<SUP> </SUP>of Ser<SUP>473</SUP> may occur
through an autophosphorylation mechanism (<A HREF="#B8">8</A>). However,<SUP> </SUP>it should be
pointed out that, in our studies, the PDK1<SUP>A280V</SUP>-induced PKB
phosphorylation at Ser<SUP>473</SUP> is normally less than 20% of
that stimulated by insulin. In addition,<SUP> </SUP>it has previously been shown
that a kinase-inactive, membrane-targeted<SUP> </SUP>mutant PKB can be
phosphorylated at both Thr<SUP>308</SUP> and Ser<SUP>473</SUP> in
unstimulated cells (<A HREF="#B9">9</A>). Consistent with these results,<SUP> </SUP>we have found
that a disruption of the kinase activity of the<SUP> </SUP>enzyme inhibited PKB
phosphorylation at both Thr<SUP>308</SUP> and Ser<SUP>473</SUP>(Fig.
<a href="#F3">3</a>). In addition, inactivation of PKB did not completely<SUP> </SUP>inhibit
insulin-stimulated PKB phosphorylation at Ser<SUP>473</SUP> (Fig. <a href="#F3">3</a>).
Therefore, it remains to be established whether the<SUP> </SUP>growth
factor-stimulated stoichiometric phosphorylation of PKB<SUP> </SUP>at this site is
mediated by autophosphorylation, by a distinct<SUP> </SUP>kinase, or by<SUP> </SUP>both.
    
    </P>

    
    <P>It has recently been shown that, upon binding to the PIF</A> fragment
derived from PRK2, PDK1</A> is capable of phosphorylating PKB<SUP> </SUP>at
Ser<SUP>473</SUP> (<A HREF="#B7">7</A>). In agreement with this finding, we found that
co-expression<SUP> </SUP>of PDK1<SUP>A280V</SUP> with the PIF</A> fragment led to an
increase of PKB phosphorylation<SUP> </SUP>at Ser<SUP>473</SUP> (Fig.
<a href="#F1">1</a><I>C</I>, <I>second panel</I>, <I>lane 3&nbsp;versus 5</I>). However, we also found<SUP> </SUP>that
co-expression of full-length PRK2, its isoform PRK1/PKN,<SUP> </SUP>or the
carboxyl terminus of PRK1/PKN (PKN-AF3) inhibited
PDK1<SUP>A280V</SUP>-mediated PKB phosphorylation at both
Thr<SUP>308</SUP> and Ser<SUP>473</SUP> (Fig. <a href="#F1">1</a>, <I>B</I> and
<I>C</I>). These findings suggest the full-length PRK1/PKN<SUP> </SUP>and PRK2
play negative roles in PDK1-mediated phosphorylation<SUP> </SUP>of PKB in<SUP> </SUP>cells.
    
    


<BR><BR CLEAR=ALL>

</TXT>



<!-- Stray figures and tables -->


<!-- Acknowledgements -->

<A NAME="ack"><!-- comment for mosaic --></A>

<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ACKNOWLEDGEMENTS</FONT></TH>
</TR>
</TABLE>


<P>We thank Dr. Richard A.&nbsp;Roth for CHO/IR cells
and PKB<IMG SRC="/math/12pt/normal/alpha.gif" ALIGN=BASELINE ALT="alpha "> cDNA, Dr. Dario R.&nbsp;Alessi for the GST-PIF construct,
Drs. Hideyuki<SUP> </SUP>Mukai and Yoshitaka Ono for the plasmid encoding AF3-PKN,
Lindsay<SUP> </SUP>L.&nbsp;Ellis and Dr. Huili He for carrying out some initial
experiments<SUP> </SUP>described in this study, and Dr. Mei Ann Lim for insightful
comments<SUP> </SUP>on the<SUP> </SUP>manuscript.
</P>

<!-- Notes -->


<!-- Footnotes -->

<A NAME="foo"><!-- comment for mosaic --></A>

<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;FOOTNOTES</FONT></TH>
</TR>
</TABLE>



<P><A NAME="FN150"><SUP>*</SUP></A>
This research was supported by a Research Award from the
American Diabetes Association (to F.&nbsp;L.) and by National Institutes<SUP> </SUP>of
Health Grant DK56166 (to F.&nbsp;L. and L.&nbsp;Q.&nbsp;D.).The costs of publication<SUP> </SUP>of this
article were defrayed in part by the
payment of page charges.<SUP> </SUP>The article
must therefore be hereby marked
"<I>advertisement</I>" in<SUP> </SUP>accordance with 18&nbsp;U.S.C. Section
1734&nbsp;solely to indicate this<SUP> </SUP>fact.

<P>
<P><A NAME="FN154"><SUP>&#182;</SUP></A>
To whom correspondence should be addressed: Dept. of
Pharmacology, The University of Texas Health Science Center, 7703&nbsp;Floyd<SUP> </SUP>Curl Dr., San Antonio, TX 78229.&nbsp;Tel.: 210-567-3097; Fax: 210-567-4226;<SUP> </SUP>E-mail: liuf@uthscsa.edu.

<P>


<P>
Published, JBC Papers in Press, September 26,&nbsp;2000,&nbsp;DOI 10.1074/jbc.M003937200

<P>
<P><A NAME="FN2"><SUP>2</SUP></A>
M. J.&nbsp;Wilk, H.&nbsp;He, and F.&nbsp;Liu, unpublished<SUP> </SUP>results.

<P>

<A NAME="abb"><!-- comment for mosaic --></A>

<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;ABBREVIATIONS</FONT></TH>
</TR>
</TABLE>

<P>The abbreviations used are: 

PKB/Akt, protein
kinase B;

CHO, Chinese hamster ovary;

GST, glutathione s-transferase;

IR, insulin receptor;

PAGE, polyacrylamide gel
electrophoresis;

PDK1, 3-phosphoinositide-dependent
protein kinase-1;

PI3K, phosphatidylinositol 3-kinase;

PIF, PDK1-interacting fragment;

PKN, protein kinase N;

PRK, protein kinase
C-related kinase;

PtdIns, phosphatidylinositide;

PCR, polymerase chain
reaction.

</P>


<!-- Appendices -->

<!-- Bibliography -->




<A NAME="References"><!-- null --></A>
<BR CLEAR=ALL><TABLE WIDTH=100% BGCOLOR=E1E1E1 CELLPADDING=0 CELLSPACING=0>
<TR>
<TD ALIGN=LEFT VALIGN=MIDDLE WIDTH=5% BGCOLOR=FFFFFF>&nbsp;<IMG WIDTH=10 HEIGHT=21 HSPACE=5 ALT="" SRC="/icons/toc/rarrow.gif"></TD>
<TH ALIGN=LEFT VALIGN=MIDDLE WIDTH=95%><FONT SIZE=+2>&nbsp;&nbsp;REFERENCES</FONT></TH>
</TR>
</TABLE>

<TABLE ALIGN=RIGHT CELLPADDING=5 BORDER NOWRAP><R>
<TH ALIGN=LEFT>
<FONT SIZE=-1>



<A HREF="#Top"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">TOP</A>


<BR>
<A HREF="#Abstract"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">ABSTRACT</A>


<BR>
<A HREF="#Introduction"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">INTRODUCTION</A>


<BR>
<A HREF="#SEC1"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">EXPERIMENTAL PROCEDURES</A>


<BR>
<A HREF="#SEC2"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">RESULTS</A>


<BR>
<A HREF="#SEC3"><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/uarrow.gif">DISCUSSION</A>


<BR><IMG WIDTH=11 HEIGHT=9 BORDER=0 HSPACE=5 SRC="/icons/toc/dot.gif"><FONT COLOR=46
4C53>REFERENCES</FONT>
</FONT></TH>
</TR></TABLE>

<BR CLEAR=ALL>
<BR CLEAR=ALL><TABLE BORDER=0>
<TR><TD VALIGN=TOP><a name="B1">1.</a>
    <TD VALIGN=TOP>

Coffer, P. J.,
Jin, J.,
 and Woodgett, J. R.



(1998)

<I>Biochem. J.</I>
<B>335</B>,
1-13<!-- HIGHWIRE ID="275:51:40400:1" --><A HREF="/cgi/external_ref?access_num=9742206&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9742206&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B2">2.</a>
    <TD VALIGN=TOP>

Vanhaesebroeck, B.,
 and Alessi, D. R.



(2000)

<I>Biochem. J.</I>
<B>346</B>,
561-567<!-- HIGHWIRE ID="275:51:40400:2" --><A HREF="/cgi/external_ref?access_num=10.1042/0264-6021:3460561&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10698680&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10698680&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B3">3.</a>
    <TD VALIGN=TOP>

Meier, R.,
 and Hemmings, B. A.



(1999)

<I>J. Recept. Signal Transduct. Res.</I>
<B>19</B>,
121-128<!-- HIGHWIRE ID="275:51:40400:3" --><A HREF="/cgi/external_ref?access_num=10071752&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10071752&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B4">4.</a>
    <TD VALIGN=TOP>

Alessi, D. R.,
Deak, M.,
Casamayor, A.,
Caudwell, F. B.,
Morrice, N.,
Norman, D. G.,
Gaffney, P.,
Reese, C. B.,
MacDougall, C. N.,
Harbison, D.,
Ashworth, A.,
 and Bownes, M.



(1997)

<I>Curr. Biol.</I>
<B>7</B>,
776-789<!-- HIGHWIRE ID="275:51:40400:4" --><A HREF="/cgi/external_ref?access_num=9368760&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9368760&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B5">5.</a>
    <TD VALIGN=TOP>

Stephens, L.,
Anderson, K.,
Stokoe, D.,
Erdjument-Bromage, H.,
Painter, G. F.,
Holmes, A. B.,
Gaffney, P. R.,
Reese, C. B.,
McCormick, F.,
Tempst, P.,
Coadwell, J.,
 and Hawkins, P. T.



(1998)

<I>Science</I>
<B>279</B>,
710-714<!-- HIGHWIRE ID="275:51:40400:5" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=sci&resid=279/5351/710"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B6">6.</a>
    <TD VALIGN=TOP>

Alessi, D. R.,
James, S. R.,
Downes, C. P.,
Holmes, A. B.,
Gaffney, P. R.,
Reese, C. B.,
 and Cohen, P.



(1997)

<I>Curr. Biol.</I>
<B>7</B>,
261-269<!-- HIGHWIRE ID="275:51:40400:6" --><A HREF="/cgi/external_ref?access_num=9094314&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9094314&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B7">7.</a>
    <TD VALIGN=TOP>

Balendran, A.,
Casamayor, A.,
Deak, M.,
Paterson, A.,
Gaffney, P.,
Currie, R.,
Downes, C. P.,
 and Alessi, D. R.



(1999)

<I>Curr. Biol.</I>
<B>9</B>,
393-404<!-- HIGHWIRE ID="275:51:40400:7" --><A HREF="/cgi/external_ref?access_num=10.1016/S0960-9822(99)80186-9&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10226025&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10226025&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B8">8.</a>
    <TD VALIGN=TOP>

Toker, A.,
 and Newton, A. C.



(2000)

<I>J. Biol. Chem.</I>
<B>275</B>,
8271-8274<!-- HIGHWIRE ID="275:51:40400:8" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/12/8271"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B9">9.</a>
    <TD VALIGN=TOP>

Andjelkovic, M.,
Alessi, D. R.,
Meier, R.,
Fernandez, A.,
Lamb, N. J.&nbsp;C.,
Frech, M.,
Cron, P.,
Cohen, P.,
Lucocq, J. M.,
 and Hemmings, B. A.



(1997)

<I>J. Biol. Chem.</I>
<B>272</B>,
31515-31524<!-- HIGHWIRE ID="275:51:40400:9" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=272/50/31515"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B10">10.</a>
    <TD VALIGN=TOP>

Kohn, A. D.,
Kovacina, K.,
 and Roth, R. A.



(1995)

<I>EMBO J.</I>
<B>14</B>,
4288-4295<!-- HIGHWIRE ID="275:51:40400:10" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=emboj&resid=14/17/4288">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B11">11.</a>
    <TD VALIGN=TOP>

Kohn, A. D.,
Takeuchi, F.,
 and Roth, R. A.



(1996)

<I>J. Biol. Chem.</I>
<B>271</B>,
21920-21926<!-- HIGHWIRE ID="275:51:40400:11" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=271/36/21920"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B12">12.</a>
    <TD VALIGN=TOP>

Zhou, H.,
Summers, S. A.,
Birnbaum, M. J.,
 and Pittman, R. N.



(1998)

<I>J. Biol. Chem.</I>
<B>273</B>,
16568-16575<!-- HIGHWIRE ID="275:51:40400:12" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=273/26/16568"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B13">13.</a>
    <TD VALIGN=TOP>

Dong, L. Q.,
Zhang, L.-B.,
Langlais, P.,
He, H.,
Clark, M.,
Zhu, L.,
 and Liu, F.



(1999)

<I>J. Biol. Chem.</I>
<B>274</B>,
8117-8122<!-- HIGHWIRE ID="275:51:40400:13" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=274/12/8117"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B14">14.</a>
    <TD VALIGN=TOP>

Takahashi, M.,
Mukai, H.,
Toshimori, M.,
Miyamoto, M.,
 and Ono, Y.



(1998)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>95</B>,
11566-11571<!-- HIGHWIRE ID="275:51:40400:14" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=95/20/11566"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B15">15.</a>
    <TD VALIGN=TOP>

Kunkel, T. A.,
Roberts, J. D.,
 and Zakour, R. A.



(1987)

<I>Methods Enzymol.</I>
<B>154</B>,
367-383<!-- HIGHWIRE ID="275:51:40400:15" --><A HREF="/cgi/external_ref?access_num=3323813&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=3323813&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B16">16.</a>
    <TD VALIGN=TOP>

Paradis, S.,
Ailion, M.,
Toker, A.,
Thomas, J. H.,
 and Ruvkun, G.



(1999)

<I>Genes Dev.</I>
<B>13</B>,
1438-1452<!-- HIGHWIRE ID="275:51:40400:16" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=genesdev&resid=13/11/1438"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B17">17.</a>
    <TD VALIGN=TOP>

Dong, L. Q.,
Landa, L. R.,
Wick, M. J.,
Zhu, L.,
Mukai, H.,
Ono, Y.,
 and Liu, F.



(2000)

<I>Proc. Natl. Acad. Sci. U.&nbsp;S.&nbsp;A.</I>
<B>97</B>,
5089-5094<!-- HIGHWIRE ID="275:51:40400:17" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=pnas&resid=97/10/5089"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B18">18.</a>
    <TD VALIGN=TOP>

Wang, C. N.,
O'Brien, L.,
 and Brindley, D. N.



(1998)

<I>Diabetes</I>
<B>47</B>,
24-31<!-- HIGHWIRE ID="275:51:40400:18" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=diabetes&resid=47/1/24">[Abstract]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B19">19.</a>
    <TD VALIGN=TOP>

Summers, S. A.,
Garza, L. A.,
Xhou, H.,
 and Birnbaum, M. J.



(1998)

<I>Mol. Cell. Biol.</I>
<B>18</B>,
5457-5464<!-- HIGHWIRE ID="275:51:40400:19" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=18/9/5457"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B20">20.</a>
    <TD VALIGN=TOP>

Anderson, K. E.,
Coadwell, J.,
Stephens, L. R.,
 and Hawkins, P. T.



(1998)

<I>Curr. Biol.</I>
<B>8</B>,
684-691<!-- HIGHWIRE ID="275:51:40400:20" --><A HREF="/cgi/external_ref?access_num=9637919&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9637919&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B21">21.</a>
    <TD VALIGN=TOP>

Currie, R. A.,
Walker, K. S.,
Gray, A.,
Deak, M.,
Casamayor, A.,
Downes, C. P.,
Cohen, P.,
Alessi, D. R.,
 and Lucocq, J.



(1999)

<I>Biochem. J.</I>
<B>337</B>,
575-583<!-- HIGHWIRE ID="275:51:40400:21" --><A HREF="/cgi/external_ref?access_num=10.1042/0264-6021:3370575&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=9895304&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=9895304&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B22">22.</a>
    <TD VALIGN=TOP>

Hill, M. M.,
Clark, S. F.,
Tucker, D. F.,
Birnbaum, M. J.,
James, D. E.,
 and Macaulay, S. L.



(1999)

<I>Mol. Cell. Biol.</I>
<B>19</B>,
7771-7781<!-- HIGHWIRE ID="275:51:40400:22" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=19/11/7771"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B23">23.</a>
    <TD VALIGN=TOP>

Filippa, N.,
Sable, C. L.,
Hemmings, B. A.,
 and Van Obberghen, E.



(2000)

<I>Mol. Cell. Biol.</I>
<B>20</B>,
5712-5722<!-- HIGHWIRE ID="275:51:40400:23" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=mcb&resid=20/15/5712"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B24">24.</a>
    <TD VALIGN=TOP>

Belham, C.,
Wu, S.,
 and Avruch, J.



(1999)

<I>Curr. Biol.</I>
<B>9</B>,
R93-R96<!-- HIGHWIRE ID="275:51:40400:24" --><A HREF="/cgi/external_ref?access_num=10.1016/S0960-9822(99)80058-X&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10021376&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10021376&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B25">25.</a>
    <TD VALIGN=TOP>

Peterson, R. T.,
 and Schreiber, S. L.



(1999)

<I>Curr. Biol.</I>
<B>9</B>,
R521-R524<!-- HIGHWIRE ID="275:51:40400:25" --><A HREF="/cgi/external_ref?access_num=10.1016/S0960-9822(99)80326-1&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10421571&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10421571&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B26">26.</a>
    <TD VALIGN=TOP>

King, C. C.,
Zende, F. T.,
Dawson, P. E.,
Dutil, E. M.,
Newton, A. C.,
Hemmings, B. A.,
 and Bokoch, G. M.



(2000)

<I>J. Biol. Chem.</I>
<B>275</B>,
18108-18113<!-- HIGHWIRE ID="275:51:40400:26" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/24/18108"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B27">27.</a>
    <TD VALIGN=TOP>

Schubert, K. M.,
Scheid, M. P.,
 and Duronio, V.



(2000)

<I>J. Biol. Chem.</I>
<B>275</B>,
13330-13335<!-- HIGHWIRE ID="275:51:40400:27" --><A HREF="/cgi/ijlink?linkType=ABST&journalCode=jbc&resid=275/18/13330"><nobr>[Abstract/<font COLOR="CC0000">Free</font> Full&nbsp;Text]</nobr></A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B28">28.</a>
    <TD VALIGN=TOP>

Casamayor, A.,
Morrice, N. A.,
 and Alessi, D. R.



(1999)

<I>Biochem. J.</I>
<B>342</B>,
287-292<!-- HIGHWIRE ID="275:51:40400:28" --><A HREF="/cgi/external_ref?access_num=10.1042/0264-6021:3420287&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10455013&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10455013&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>
<TR><TD VALIGN=TOP><a name="B29">29.</a>
    <TD VALIGN=TOP>

Salinas, M.,
Lopez-Valdaliso, R.,
Martin, D.,
Alvarez, A.,
 and Cuadrado, A.



(2000)

<I>Mol. Cell Neurosci.</I>
<B>15</B>,
156-169<!-- HIGHWIRE ID="275:51:40400:29" --><A HREF="/cgi/external_ref?access_num=10.1006/mcne.1999.0813&link_type=DOI">[CrossRef]</A><A HREF="/cgi/external_ref?access_num=10673324&link_type=MED">[Medline]</A> 
<A HREF="/cgi/external_ref?access_num=10673324&displayid=77141&link_type=INFOTRIEVE">[Order&nbsp;article&nbsp;via&nbsp;Infotrieve]</A><!-- /HIGHWIRE -->
    </TR>

</TABLE>



<P><HR>
<FONT SIZE=-1><A HREF="/misc/terms.shtml"><B>Copyright &#169; 2000 by The American Society for Biochemistry and Molecular Biology, Inc.</B></A></FONT>




<!--

   Pages created by the Electronic Press Engine from

		Atypon Systems, Inc.

   Visit http://www.atypon.com/

-->


</vardef>

		
        
        
	
	
	



 




<BR CLEAR=ALL>




<A NAME="otherarticles"><!-- null --></A>
<P>
<FONT SIZE=+2><STRONG>This article has been cited by other articles:</STRONG></FONT>
<P>




<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://jb.oupjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://jb.oupjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://jb.oupjournals.org"><IMG ALT="J. Biochem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbiochem.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	H. Mukai<BR>
	<STRONG>The Structure and Function of PKN, a Protein Kinase Having a Catalytic Domain Homologous to That of PKC</STRONG><BR>
	
		
			J. Biochem. (Tokyo),
		
	
        
        January&nbsp;1,&nbsp;2003;
	133(1):
	17 - 27.
<BR>
<A HREF="http://jb.oupjournals.org/cgi/content/abstract/133/1/17">[Abstract]</A>

<A HREF="http://jb.oupjournals.org/cgi/content/full/133/1/17">[Full Text]</A>
<A HREF="http://jb.oupjournals.org/cgi/reprint/133/1/17">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. R. Wick, E. D. Werner, P. Langlais, F. J. Ramos, L. Q. Dong, S. E. Shoelson, and F. Liu<BR>
	<STRONG>Grb10 Inhibits Insulin-stimulated Insulin Receptor Substrate (IRS)-Phosphatidylinositol 3-Kinase/Akt Signaling Pathway by Disrupting the Association of IRS-1/IRS-2 with the Insulin Receptor</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        March&nbsp;7,&nbsp;2003;
	278(10):
	8460 - 8467.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/278/10/8460">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/278/10/8460">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/278/10/8460">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://ajpgi.physiology.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://ajpgi.physiology.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://ajpgi.physiology.org"><IMG ALT="Am. J. Physiol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/ajpgi.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	J. F. Kuemmerle<BR>
	<STRONG>IGF-I elicits growth of human intestinal smooth muscle cells by activation of PI3K, PDK-1, and p70S6 kinase</STRONG><BR>
	
		
			Am J Physiol Gastrointest Liver Physiol,
		
	
        
        March&nbsp;1,&nbsp;2003;
	284(3):
	G411 - 422.
<BR>
<A HREF="http://ajpgi.physiology.org/cgi/content/abstract/284/3/G411">[Abstract]</A>

<A HREF="http://ajpgi.physiology.org/cgi/content/full/284/3/G411">[Full Text]</A>
<A HREF="http://ajpgi.physiology.org/cgi/reprint/284/3/G411">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	L. Smith and J. B. Smith<BR>
	<STRONG>Lack of Constitutive Activity of the Free Kinase Domain of Protein Kinase C zeta . DEPENDENCE ON TRANSPHOSPHORYLATION OF THE ACTIVATION LOOP</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        November&nbsp;29,&nbsp;2002;
	277(48):
	45866 - 45873.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/48/45866">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/48/45866">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/48/45866">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Sato, N. Fujita, and T. Tsuruo<BR>
	<STRONG>Regulation of Kinase Activity of 3-Phosphoinositide-dependent Protein Kinase-1 by Binding to 14-3-3</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;18,&nbsp;2002;
	277(42):
	39360 - 39367.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/42/39360">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/42/39360">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/42/39360">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	K. Egawa, H. Maegawa, K. Shi, T. Nakamura, T. Obata, T. Yoshizaki, K. Morino, S. Shimizu, Y. Nishio, E. Suzuki, and A. Kashiwagi<BR>
	<STRONG>Membrane Localization of 3-Phosphoinositide-dependent Protein Kinase-1 Stimulates Activities of Akt and Atypical Protein Kinase C but Does Not Stimulate Glucose Transport and Glycogen Synthesis in 3T3-L1 Adipocytes</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;11,&nbsp;2002;
	277(41):
	38863 - 38869.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/41/38863">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/41/38863">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/41/38863">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://ajplung.physiology.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://ajplung.physiology.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://ajplung.physiology.org"><IMG ALT="Am. J. Physiol." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/ajplung.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	Y. D. Li, E. R. Block, and J. M. Patel<BR>
	<STRONG>Activation of multiple signaling modules is critical in angiotensin IV-induced lung endothelial cell proliferation</STRONG><BR>
	
		
			Am J Physiol Lung Cell Mol Physiol,
		
	
        
        October&nbsp;1,&nbsp;2002;
	283(4):
	L707 - 716.
<BR>
<A HREF="http://ajplung.physiology.org/cgi/content/abstract/283/4/L707">[Abstract]</A>

<A HREF="http://ajplung.physiology.org/cgi/content/full/283/4/L707">[Full Text]</A>
<A HREF="http://ajplung.physiology.org/cgi/reprint/283/4/L707">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	S. Arico, S. Pattingre, C. Bauvy, P. Gane, A. Barbat, P. Codogno, and E. Ogier-Denis<BR>
	<STRONG>Celecoxib Induces Apoptosis by Inhibiting 3-Phosphoinositide-dependent Protein Kinase-1 Activity in the Human Colon Cancer HT-29 Cell Line</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        August&nbsp;2,&nbsp;2002;
	277(31):
	27613 - 27621.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/31/27613">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/31/27613">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/31/27613">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. J. Wick, K. R. Wick, H. Chen, H. He, L. Q. Dong, M. J. Quon, and F. Liu<BR>
	<STRONG>Substitution of the Autophosphorylation Site Thr516 with a Negatively Charged Residue Confers Constitutive Activity to Mouse 3-Phosphoinositide-dependent Protein Kinase-1 in Cells</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        May&nbsp;10,&nbsp;2002;
	277(19):
	16632 - 16638.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/277/19/16632">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/277/19/16632">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/277/19/16632">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	M. J. Wick, L. Q. Dong, D. Hu, P. Langlais, and F. Liu<BR>
	<STRONG>Insulin Receptor-mediated p62dok Tyrosine Phosphorylation at Residues 362 and 398 Plays Distinct Roles for Binding GTPase-activating Protein and Nck and Is Essential for Inhibiting Insulin-stimulated Activation of Ras and Akt</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        November&nbsp;16,&nbsp;2001;
	276(46):
	42843 - 42850.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/46/42843">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/46/42843">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/46/42843">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://www.jbc.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://www.jbc.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://www.jbc.org"><IMG ALT="J. Biol. Chem." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/jbc.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	L. Wang, F. Liu, and M. L. Adamo<BR>
	<STRONG>Cyclic AMP Inhibits Extracellular Signal-regulated Kinase and Phosphatidylinositol 3-Kinase/Akt Pathways by Inhibiting Rap1</STRONG><BR>
	
		
			J. Biol. Chem.,
		
	
        
        October&nbsp;5,&nbsp;2001;
	276(40):
	37242 - 37249.
<BR>
<A HREF="http://www.jbc.org/cgi/content/abstract/276/40/37242">[Abstract]</A>

<A HREF="http://www.jbc.org/cgi/content/full/276/40/37242">[Full Text]</A>
<A HREF="http://www.jbc.org/cgi/reprint/276/40/37242">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://diabetes.diabetesjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://diabetes.diabetesjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://diabetes.diabetesjournals.org"><IMG ALT="Diabetes" WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/diabetes.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. Cazzolli, L. Carpenter, T. J. Biden, and C. Schmitz-Peiffer<BR>
	<STRONG>A Role for Protein Phosphatase 2A-Like Activity, but Not Atypical Protein Kinase C{zeta}, in the Inhibition of Protein Kinase B/Akt and Glycogen Synthesis by Palmitate</STRONG><BR>
	
		
			Diabetes,
		
	
        
        October&nbsp;1,&nbsp;2001;
	50(10):
	2210 - 2218.
<BR>
<A HREF="http://diabetes.diabetesjournals.org/cgi/content/abstract/50/10/2210">[Abstract]</A>

<A HREF="http://diabetes.diabetesjournals.org/cgi/content/full/50/10/2210">[Full Text]</A>

<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>



<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" WIDTH="600">

<TR BGCOLOR="#D9D4C5">

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="25"><IMG ALT="" WIDTH="25" HEIGHT="5" SRC="/icons/spacer.gif"><BR>

</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>

<TD ALIGN="CENTER" VALIGN="TOP" WIDTH="61" NOWRAP>
	<A HREF="http://emboj.oupjournals.org"><IMG ALT="Home page" WIDTH="59" HEIGHT="80" VSPACE="5" BORDER="1" SRC="http://emboj.oupjournals.org/portal_imgs/search_result.gif"></A><BR>
</TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
<TD VALIGN="TOP" WIDTH="499" NOWRAP>
<A HREF="http://emboj.oupjournals.org"><IMG ALT="EMBO J." WIDTH="450" HEIGHT="16" VSPACE="5" BORDER="0" SRC="/icons/shared/searchall/journals/emboj.gif"><IMG ALT="Home page" BORDER="0" WIDTH="49" HEIGHT="16" VSPACE="5" SRC="/icons/shared/search/homelink.gif"></A><BR>
<FONT SIZE="-1" FACE="verdana,arial,helvetica">
	R. M. Biondi, A. Kieloch, R. A. Currie, M. Deak, and D. R. Alessi<BR>
	<STRONG>The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB</STRONG><BR>
	
		
			EMBO J.,
		
	
        
        August&nbsp;15,&nbsp;2001;
	20(16):
	4380 - 4390.
<BR>
<A HREF="http://emboj.oupjournals.org/cgi/content/abstract/20/16/4380">[Abstract]</A>

<A HREF="http://emboj.oupjournals.org/cgi/content/full/20/16/4380">[Full Text]</A>
<A HREF="http://emboj.oupjournals.org/cgi/reprint/20/16/4380">[PDF]</A>
<BR><IMG ALT="" WIDTH="499" HEIGHT="1" SRC="/icons/spacer.gif">
</FONT></TD>
<TD WIDTH="5"><IMG ALT="" WIDTH="5" HEIGHT="5" SRC="/icons/spacer.gif"></TD>
</TR>
<TR><TD COLSPAN="6"><HR NOSHADE SIZE="1" WIDTH="600" COLOR="#828282" ALIGN="LEFT"></TD></TR>
</TABLE>










<BR CLEAR=ALL>
<BR CLEAR=ALL>


	
	 
		  
			                    
	


	
		<!-- beginning of outer tables -->
               
                
                <TABLE CELLPADDING=4
                ALIGN=RIGHT
                
                CELLPADDING=5 HSPACE=4 VSPACE=4 BORDER NOWRAP>
               
		<TR><TD ALIGN=LEFT NOWRAP>

		<!-- beginning of inner table -->
				<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
		
		
	 
	
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/content/abstract/275/51/40400">Abstract of this Article</A>  (<img src="/icons/shared/toc/free.gif">)
			</FONT></TD></TR>
		
		
	


		
		
		

		
		
		


		
		
		

		
		
		

		
		
		

		
                
                

		
	


		

		
	

		
		

		
		 

		
		 
	 		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">

			
			 

			
			

						
				
				<STRONG><A HREF="/cgi/reprint/275/51/40400">Reprint (PDF) Version of this Article</A>
 				
			

			

		</FONT></TD></TR>
		
		


                
                


		


	



		



		
		

		
		
		
	


		


		

		

		
		
			
			
			
				<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				<A HREF="/cgi/citemap?id=jbc;275/51/40400">Citation Map</A>
				</FONT></TD></TR>
		


		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/mailafriend?url=http://www.jbc.org/cgi/content/full/275/51/40400&title=Mechanism+of+Phosphorylation+of+Protein+Kinase+B%2FAkt+by+a+Constitutively+Active+3-Phosphoinositide-dependent+Protein+Kinase-1">Email this article to a friend</A>
		</FONT></TD></TR>
		


		 
		
		


	
	
	
	
		
		
		
		
	
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			Similar articles found in:<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/search?qbe=jbc;M003937200&journalcode=jbc&minscore=5000"><FONT SIZE="-1">JBC Online</FONT></A>
				
				
				<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/external_ref?access_num=11006271&link_type=MED_NBRS"><FONT SIZE="-1">PubMed</FONT></A>
		</FONT></TD></TR>
		
		
	
	
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		<A HREF="/cgi/external_ref?access_num=11006271&link_type=PUBMED">PubMed Citation</A>
	</FONT></TD></TR>
	
	

		
		
		
		
		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
				This Article has been cited by:
			</FONT></TD></TR>
		

		
		
		


                
                


                
                

		
		
		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		
			Search PubMed for articles by:<BR>
			<IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">
			
				<A HREF="/cgi/external_ref?access_num=Wick+MJ&link_type=AUTHORSEARCH">Wick, M. J.</A>
				 || 
			
				<A HREF="/cgi/external_ref?access_num=Liu+F&link_type=AUTHORSEARCH">Liu, F.</A>
				
			
		
		</FONT></TD></TR>
		

		
		



		



		


		
		
		
		<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
		Alert me when:
		<BR><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><IMG WIDTH=9 HEIGHT=9 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/alerts/ctalert?alertType=citedby&addAlert=cited_by&saveAlert=no&cited_by_criteria_resid=jbc;275/51/40400&return_type=article&return_url=%2Fcgi%2Fcontent%2Ffull%2F275%2F51%2F40400"><FONT SIZE="-1">new articles cite this article</FONT></A><BR>
		</FONT></TD></TR>


		


		
		


		
		
		
			<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
			<A HREF="/cgi/citmgr?gca=jbc;275/51/40400">Download to Citation Manager</A>
		</FONT></TD></TR>
		
		

		
		</TABLE> 
		</TD></TR> <!-- end of inner content box -->




		
		
		
		


		
        <!-- 1xxx --><!-- 2xxx --><!-- 3xxx --><!-- 4xxx --><!-- 5xxx -->         
	        <TR><TD ALIGN=LEFT NOWRAP>   <!-- revisions table -->
		

	
	<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="1" NOWRAP>
	<TR><TD><IMG WIDTH=9 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/toc/rarrowsm.gif"><FONT SIZE="-1">
	All Versions of this Article:	
	</FONT></TD></TR>
	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif">275/51/40400<FONT COLOR="#A70716"> (most recent)</FONT></FONT></TD></TR>
	         

	         
	<TR><TD ALIGN=LEFT NOWRAP><FONT SIZE=-1><IMG WIDTH=27 HEIGHT=11 ALIGN=BASELINE ALT="" BORDER=0 SRC="/icons/spacer.gif"><A HREF="/cgi/content/short/M003937200v1">M003937200v1</A></FONT></TD></TR>
	
	</TABLE>
	         

    
		</TD></TR>
        
        
	</TABLE>	 <!-- end of outer content box -->
	


					
	

<BR CLEAR=ALL>

        
	<P>
	<HR NOSHADE ALIGN="LEFT" WIDTH="450" SIZE="1">
	
	<TABLE CELLPADDING="2" CELLSPACING="2" WIDTH="450">
	<TR>
		<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HOME</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/help/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">HELP</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/cgi/feedback"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">FEEDBACK</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/subscriptions/"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SUBSCRIPTIONS</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/contents-by-date.0.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">ARCHIVE</FONT></A></TD>
	    <TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/search.dtl"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">SEARCH</FONT></A></TD>
	    


<TD ALIGN="CENTER" VALIGN="MIDDLE" BGCOLOR="#006699" NOWRAP><A TARGET="_top" STYLE="text-decoration: none" HREF="/content/vol275/issue51/index.shtml"><FONT SIZE="-2" COLOR="#FFFFFF" FACE="arial,helvetica">TABLE OF CONTENTS</FONT></A></TD>




	</TR>
	</TABLE>
	
	


	
<TABLE CELLPADDING="2" CELLSPACING="2" BORDER="0">
<TR>
        <TD BGCOLOR="#006699" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.asbmb.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">All ASBMB Journals</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#CC0000" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.mcponline.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Molecular and Cellular Proteomics</A></STRONG>&nbsp;</TD>
</TR><TR>
        <TD BGCOLOR="#0099FF" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.jlr.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Journal of Lipid Research</A></STRONG>&nbsp;</TD>
        <TD BGCOLOR="#003F77" ALIGN="CENTER" NOWRAP>&nbsp;<A STYLE="text-decoration:none" HREF="http://www.bambed.org/"><STRONG><FONT SIZE="-2" FACE="verdana,arial,helvetica" COLOR="#FFFFFF">Biochemistry and Molecular Biology Education</A></STRONG>&nbsp;</TD>
</TR>
</TABLE>

	<FONT SIZE="-1"><STRONG><A TARGET="_top" HREF="/misc/terms.shtml">Copyright &copy; 2000 by the American Society for Biochemistry and Molecular Biology.</A></STRONG></FONT>
	


</BODY>
</HTML>
